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Abstract 
Background: Although gestational diabetes mellitus (GDM) has been linked to pediatric 
obesity, there is limited research on the impact of intrauterine exposure to GDM on 
trajectories of childhood growth. Objective: To assess the effect of prenatal GDM exposure 
on childhood body mass index (BMI) trajectories. Design: Analyses were conducted using 
data from cycles 2 to 6 (1994-2004; N=3412 children) of the National Longitudinal Survey 
of Children and Youth. Latent growth curve modelling (LGCM) was used to model BMI 
trajectories from age 2 to 10 years with prenatal exposure to GDM as a predictor. Effect 
modification by breastfeeding was assessed. Results: Among males, prenatal exposure to 
GDM was associated with significantly lower initial BMI. There were no other statistically 
significant effects of prenatal exposure to GDM.  Effect modification by breastfeeding was 
not statistically significant. Conclusions: Despite mainly non-significant findings, this study 
lays the groundwork for future pediatric obesity research using LGCM. 
 
Keywords 
Maternal-child health, pediatric obesity, gestational diabetes mellitus, prenatal exposure, 
obesity risk factors, body mass index, longitudinal studies, latent growth curve modelling, 
National Longitudinal Survey of Children and Youth  
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Chapter 1  
1 Introduction and Literature Review 
1.1 Introduction 
Obesity is a morbid condition that is reducing the quality of life for increasing numbers 
of children and youth.
1
  Over the past few decades, the prevalence of childhood 
overweight and obesity has escalated in Canada and worldwide.
2 3
 These trends are 
important because of the social stigma and reduced quality of life associated with being 
overweight
4
 as well as the myriad of comorbidities linked to obesity.
4 5
  Indeed, as a 
result of the childhood obesity epidemic, children are experiencing earlier onset of 
chronic conditions once considered to be limited to adulthood.
6
 Obese children are also at 
greater risk for adult obesity
7
 and death in adulthood due to cardiovascular disease.
8 9
 
Strategies for prevention are becoming ever more important in light of these trends, not 
only to improve quality of life and reduce morbidity and mortality, but to conserve 
medical resources and lessen the overall burden of obesity on the Canadian health care 
system.   
One area of research that is important for the development of targeted prevention 
strategies for childhood obesity is that which examines the developmental origins of 
overweight. There is a growing body of literature that suggests certain prenatal exposures 
are associated with increased risk of overweight and obesity in childhood and even 
adulthood.  One such risk factor that has been extensively studied is prenatal exposure to 
maternal impaired glucose tolerance (IGT) during pregnancy, and in particular, to 
gestational diabetes mellitus (GDM). GDM is a state of glucose intolerance that arises or 
is first recognized during pregnancy.
10
 The principal theory for the biological mechanism 
linking GDM to childhood overweight, at its earliest stage of the mechanistic pathway, 
suggests that poor maternal glycemic control at critical stages in fetal development leads 
to fetal hyperglycemia, which triggers fetal hyperinsulinemia.
11
 Fetal hyperinsulinemia is 
theorized to promote offspring overweight by stimulating fetal growth, resulting in 
macrosomia or very high birth weight, and programming hormones that regulate appetite 
2 
 
and food intake, resulting in postnatal risk of obesity in offspring.
12-15
  
Despite recognition of this association, the evidence supporting GDM as a risk factor to 
target for childhood overweight and obesity prevention has been somewhat 
underwhelming. This may be due, in part, to inconsistency in study outcomes. The 
majority of studies that have examined the impact of maternal IGT during pregnancy on 
weight status at a single point in childhood have varied timing of outcome evaluation. 
Furthermore, studies use different standards for defining overweight and obesity in 
childhood. These are two common issues that make pooling of results across studies 
difficult and have likely lead to an overall weak body of evidence for the relationship 
between GDM and childhood overweight and obesity.  
Studies that examine this association cross-sectionally may be missing important aspects 
of the potentially complex relationship between GDM and the change in child weight 
occurring in the unobserved period.  Indeed, these studies may be erroneously concluding 
null associations between maternal IGT and childhood weight simply because of the 
limited timing of observation. A strategy to overcome these issues is to shift the focus of 
study outcomes from weight status at a single point in childhood to growth trajectories 
throughout childhood.  This will allow for observation of the onset of overweight or 
obesity at any point throughout childhood.  More importantly, childhood growth 
trajectories allow observation of growth patterns, which provide more insight into overall 
child health than weight status at a single point. Thus, an analysis of the impact of 
prenatal exposure to GDM on trajectories of childhood growth is a logical and important 
next step in determining the relationship between maternal IGT during pregnancy and 
childhood overweight and obesity. The current study takes this step by examining the 
association between prenatal exposure to GDM and early childhood BMI trajectories. 
In the sections that follow there will be a review of the literature on the prevalence, 
measurement, and etiology of childhood overweight and obesity. Section 1.2 will discuss 
the epidemic nature of child obesity by outlining the Canadian trends in prevalence of 
childhood overweight and obesity (Section 1.2.1) and obesity-related illness and chronic 
disease (Section 1.2.2). Section 1.3 will examine the various strategies used to measure 
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trends in childhood overweight and obesity at the population level, discussing current 
definitions of childhood overweight and obesity (Section 1.3.1) and the importance of 
analysing developmental patterns and growth trajectories (Section 1.3.2). The remainder 
of this chapter will cover the literature on early life risk factors for childhood overweight 
and obesity. Section 1.4 will provide an overview of perinatal contributions to pediatric 
obesity, focusing on maternal characteristics associated with childhood overweight and 
obesity (Section 1.4.1) as well as risks associated with fetal growth and early nutrition 
(Section 1.4.2). Section 1.5 presents a review of the literature on the current trends in 
GDM prevalence (Section 1.5.1), risk factors for GDM (Section 1.5.2), and issues related 
to the study of GDM in population research (Section 1.5.3).  Finally, Section 1.6 outlines 
the literature to date on the impact of exposure to GDM in utero on offspring weight, 
focusing on proposed biological mechanisms (Section 1.6.1) and the impact of GDM on 
birth weight (Section 1.6.2) and weight status throughout childhood (Section 1.6.3).  
1.2 The Epidemic of Childhood Obesity 
Worldwide, the prevalence of childhood overweight and obesity has been escalating. 
Indeed, due to the rate of increase in prevalence, childhood overweight and obesity is 
now widely recognized as an epidemic.
16
 Further, overweight and obesity in childhood 
are associated with illness and chronic disease that threaten health not only in childhood, 
but also in adulthood. The morbidity and mortality related to childhood overweight and 
obesity is detrimental both on the individual level, in terms of reduced quality of life, and 
community level, in terms of the burden on health care systems and loss of productivity.  
To evaluate the extent of the burden of this epidemic, it is important to examine recent 
trends in prevalence of pediatric obesity as well as to review the literature on obesity-
related illness and disease.  
1.2.1 Canadian Trends in Childhood Overweight and Obesity 
Trends in average weight among Canadian children over the past few decades indicate 
that, as in many other developed countries, childhood overweight and obesity is 
becoming increasingly more common. Indeed, it has been shown using three national 
databases  that between 1981 and 1996, the rate of increase in BMI was around 0.1 kg/m
2
 
4 
 
per year for Canadian children aged 7 to 13 years.
17
 That is, over this period average BMI 
for both male and female children in this age group increased by nearly 1.5 kg/m
2
.  
During this time, overweight and obesity, defined respectively by the 85
th
and 95
th 
percentiles for age- and sex-specific BMI, increased substantially.
17
 Indeed, both 
overweight and obesity approximately doubled for males and females over the 15 years.
17
 
More recently, using the 2004 Canadian Community Health Survey (CCHS), it was 
estimated that among all children and adolescents aged 2 to 17 years, 26% were either 
overweight or obese.
2
 These estimates were obtained using age- and sex-specific BMI 
cut-offs for overweight and obesity as per International Obesity TaskForce (IOTF) 
guidelines.
2
 Among 12 to 17 year-olds, the prevalence of overweight more than doubled 
from 1978 to 2004 while the prevalence of obesity tripled during the same time period.
2
 
These estimates were obtained using the 1978/1979 Canada Health Survey and the 2004 
CCHS, both of which collected direct measures of weight and height used to calculate 
BMI.
2
 
The most recent publication of The Chief Public Health Officer’s Report on the State of 
Public Health in Canada indicated that adolescent overweight and obesity is still on the 
rise.
1
 Among adolescents aged 12 to 19 years, it was estimated that 32% of males and 
27% of females were either overweight or obese, as per IOTF weight classifications for 
children.
1
 
These trends indicate that there is a pattern of increasing prevalence of overweight and 
obesity among Canadian children and adolescents that does not appear to have reached a 
plateau. This underscores the importance of identifying key determinants of childhood 
obesity as well as the urgent need for effective intervention and prevention strategies for 
childhood overweight and obesity in Canada.  
1.2.2 Obesity-Related Illness and Chronic Disease 
Perhaps the most insidious consequence of the increasing prevalence of childhood 
obesity is the myriad of diseases and other chronic health conditions associated with 
obesity that arise in childhood, adolescence, and adulthood.  Many of the comorbid health 
5 
 
conditions require lifelong care, thus creating a preventable burden on the health care 
system. Moreover, obesity-related physical health conditions that begin in childhood and 
persist throughout adulthood can cause premature death.
18
 Indeed, as suggested by 
Daniels,
19
 childhood obesity may be causing a decline in life expectancy in developed 
countries like Canada for the first time in recent history.  Hence, childhood obesity is a 
public health crisis that not only warrants attention, but immediate action to intervene and 
prevent excessive weight gain in children.  
Childhood overweight and obesity have been linked to a number of poor health outcomes 
that can present in childhood, adolescence, and adulthood.  These include type 2 
diabetes,
20 21
 hypertension,
4 22 23
 hyperlipidemia,
4 23
 fatty liver,
24
 asymptomatic 
atherosclorosis,
18 25
 and coronary heart disease (CHD).
18
 Although these were once 
considered diseases of adulthood, increasingly more children are being diagnosed with 
many of these health conditions.
19 21 26 27
 
Glucose tolerance disorders, such as type 2 diabetes, have long been associated with adult 
obesity. However, recent studies have shown an increase in type 2 diabetes diagnoses 
among overweight and obese children and youth.
4 19-21 26 27
 It has also been shown that 
among youth with type 2 diabetes, the majority are often overweight or obese, that is, 
with mean BMI ranging from ~33 kg/m
2
 to ~38 kg/m
2
 in adolescence and young 
adulthood.
26 27
 One study of a large group of 5 to 17 year-olds revealed that overweight 
individuals are 12.6 times more likely to exhibit insulin resistance than their normal 
weight counterparts.
23
 High levels of total body fat and, more specifically, abdominal fat 
have also been associated with insulin resistance among pre-pubertal children.
28
 
Abnormal levels of lipids and lipoproteins in the blood, or dyslipidemia, are associated 
with adult obesity and have been reported in pediatric populations among overweight and 
obese individuals.
4 23 29 30
 Obese adolescents exhibit increased levels of serum low-
density-lipoproteins (LDL) and triglycerides and diminished levels of serum high-
density-lipoproteins (HDL).
29
 This pattern of dyslipidemia is associated particularly with 
visceral, or abdominal, fat.
29
 It has been shown that overweight schoolchildren 5 to 17 
years of age are 2.4 times more likely to have high total cholesterol and 7.1 times more 
6 
 
likely to have high triglyceride levels than their normal weight counterparts.
23
 This trend 
in pediatric hyperlipidemia among overweight and obese children is particularly 
worrisome as hyperlipidemia in adulthood is a known risk factor for cardiovascular 
disease. It follows that obesity in childhood increases the risk of death in adulthood due 
to cardiovascular disease.
8 9
 
Although hypertension is relatively rare in pediatric populations, overweight and obesity 
in children has been linked to hypertension.
18 22 23 25 30
 Indeed, among children with 
consistently high blood pressure, the majority have been shown to be overweight or 
obese.
18 23
 It has been reported that overweight and obese individuals aged 5 to 18 years 
are 4.5 to 9 times more likely to have high blood pressure compared to normal weight 
individuals in the same age group.
4 23
 
Clustering of cardiovascular risk factors, including hypertension, insulin resistance and 
high cholesterol levels, has also been examined in pediatric populations.
23 25 30
 Studies 
have shown that the overwhelming majority of children and young adults that have more 
than two cardiovascular risk factors are overweight or obese.
23 30
 Indeed, one study 
reported that among children aged 5 to 10 years 41%, 75%, and 100% with 2, 3, or 4 
cardiovascular risk factors, respectively, were overweight.
23
 
The combination of a number of the aforementioned health conditions have been 
described together under the term "metabolic syndrome".
31
 In a report published by the 
American Heart Association, metabolic syndrome is described as a constellation of 
several cardiovascular risk factors including abdominal obesity, dyslipidemia, high blood 
pressure, and insulin resistance with or without glucose intolerance.
31
 In adults, the 
combination of these metabolic risk factors increases the risk of CHD.
31
 It has been 
estimated that the overall prevalence of metabolic syndrome in pediatric populations is 
4%, but among obese children, the prevalence is 30%.
19
   
Overweight and obesity in childhood and adolescence have a lasting impact on future 
health status. It was shown that, independent of adult weight status, overweight in 
adolescence was associated with various adverse health outcomes in adulthood, including 
all-cause mortality, disease-specific mortality, mortality due to CHD, morbidity due to 
7 
 
CHD and atherosclerosis, gout, arthritis, and colorectal cancer.
18
  
1.3 Measuring Population Trends in Childhood Obesity 
Examining trends in overweight and obesity in pediatric populations is more complex 
than in adult populations. The selection of measurement tools to determine weight status 
in children at the population level is complicated by several factors. Central to these 
factors is the issue that current definitions of pediatric overweight and obesity are not 
based on childhood morbidity. Rather, most studies examining obesity in pediatric 
populations use guidelines based on definitions for adult obesity and statistically extreme 
observations. As a result, it is unclear whether findings from studies using these 
techniques to define childhood overweight and obesity status are meaningful. It is 
therefore important to be aware of the shortcomings of current definitions of childhood 
overweight and obesity and to explore other measurement techniques that may yield more 
meaningful results.  
1.3.1 Defining Childhood Overweight and Obesity 
One of the most widely used measurement tools for defining overweight and obesity is 
the BMI, which serves to approximate body fatness by adjusting weight for height.
32
 In 
adults, definitions of overweight and obesity have been established using BMI cut points 
associated with increased risk of morbidity and mortality.
33
 Determining clinically 
relevant BMI cut points in pediatric populations is less straightforward since weight-
related health issues, such as metabolic and cardiovascular disease, present later in 
development and are generally rare in young people.
32
 Moreover, BMI throughout 
childhood is notably less consistent than in adulthood, which further complicates the task 
of defining specific cut points for overweight and obesity in children.  
Current recommendations indicate children or adolescents at the 85
th
 and 95
th
 percentiles 
for age- and sex-adjusted BMI of a particular reference pediatric population should be 
considered at risk for overweight and obesity, respectively.
34 35
 Studies examining the 
validity of these guidelines have reported generally high specificity but low sensitivity of 
these percentile cut-off values.
36-38
 Among children aged 8 to 12 years, individuals 
identified using cut points at the 85
th
 and 95
th
 percentiles for BMI were overweight and 
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obese 95% and 99% of the time, respectively.
38
 Thus, specificity of these cut points was 
high. However, these cut points failed to detect a large portion of truly overweight 
individuals, with sensitivity scores of 0.65 and 0.39 for the 85
th
 and 95
th
 percentiles for 
BMI, respectively.
38
 Such low sensitivity scores are particularly problematic for weight 
classification systems used for population surveillance or epidemiological purposes, as 
many cases of overweight and obesity are not captured.  
1.3.2 Assessing Developmental Patterns and Growth Trajectories 
In public health and medical practice, BMI cut-off values defining overweight and 
obesity in childhood are often used as screening tools rather than diagnostic tools. These 
BMI cut points flag individuals who may be at risk for weight-related health issues, but 
do not indicate per se the true level of risk for health issues in overweight and obese 
children.   
The shortcomings of current definitions of childhood overweight and obesity are 
highlighted in the findings of a study done by Bouhours-Nouet and colleagues.
39
 These 
researchers studied children aged 8 to 12 years who were obese, defined as 2 standard 
deviations above age- and sex-adjusted BMI, and collected information about birth 
weight, postnatal weight gain, and existing cardiovascular and metabolic risk factors.
39
 
Interestingly, obese children who had high weight at birth and increased weight gain in 
the first two years of life also had the highest insulin sensitivity and were thus 
metabolically healthier than obese children with low to moderate fetal and postnatal 
growth.
39
 Children with this particular growth pattern had higher insulin sensitivity even 
when compared to other high birth weight children who had less weight gain in the first 
two years of life.
39
 Moreover, obese children who had high birth weight had significantly 
lower concentrations of fat in the abdominal area as well as lower systolic blood pressure 
than obese children with low or average weight at birth.
39
  
The findings of the Bouhours-Nouet et al.
39
 study highlight two guiding concepts for 
childhood obesity research. The first is that biological processes leading to childhood 
overweight and obesity are likely active early in development.  Thus, research examining 
causes of obesity should shift focus to events occurring during prenatal and postnatal 
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growth. The second is that patterns of growth from birth throughout childhood convey 
more information about health than weight status at a single point. Consistent with this 
concept Legler and Rose
40
 discuss that from the perspective of physicians, weight status 
carries limited information about patient health. Indeed they suggest that although 
children may be at extreme ends of the BMI-for-age spectrum at various stages 
throughout development, growth that is gradual and consistent reflects good health while 
inconsistent or accelerated patterns of growth are often indicative of poor health.
40
 
Indeed, it is important to examine all aspects of early growth in order to obtain a more 
complete understanding of child health. 
Size at Birth 
A number of studies have suggested that size at birth plays an important role in later 
obesity.
41-53
 The majority of these studies’ findings indicate that high birth weight for 
gestational age, or macrosomia, is an important predictor of childhood obesity, although 
small size at birth has also been found to be associated with metabolic disease and 
obesity.
42
  
 It has been reported that high birth weight can predict overweight and obesity by as early 
as preschool age.
46 49
 Indeed, studies have shown that children born with high BMI are 
taller and heavier by the age of 3 years than their normal birth weight peers and that this 
discrepancy persists throughout early childhood.
43
  Some studies have indicated that 
children born large for gestational age (LGA) are at nearly twice the risk of being 
overweight compared to children born appropriate for gestational age (AGA).
44 48 51
 
Moreover it has been shown that among obese children, those born LGA have a much 
higher incidence of metabolic syndrome than children born AGA.
45
 Despite the fact that 
high birth weight may reflect maternal weight, its association with childhood obesity has 
been shown to be independent of maternal BMI.
46 48
 Thus, factors that affect birth weight 
independently likely play important roles in predicting childhood obesity. 
Rates of Postnatal and Childhood Growth 
Postnatal and early childhood growth rates also predict later childhood and adult obesity 
10 
 
as well as adult morbidity.
54-59
 Specifically, studies have reported that abnormally slow 
growth in height, or stunting,
54
 and abnormally rapid growth in weight resulting in 
adiposity,
55-57 59
 can increase later obesity risk.  
Children exposed to perinatal conditions that result in stunted height reportedly have 
increased risk of developing obesity in later childhood.
54
 Popkin and colleagues
54
 
examined data from several countries experiencing a “nutrition transition,” that is, a shift 
in economic conditions resulting in dietary changes that promote overweight and obesity 
in childhood. However, because of the transitional state of the countries studied, the data 
reflect pediatric populations that still experience stunted height as a result of poor 
perinatal care and infant feeding practices.
54
 After adjustment for income, stunted 
children were up to 7.8 times more likely to be overweight than non-stunted children.
54
 
The study of these low-income countries revealed that early height trajectories may be an 
important indicator of future overweight.
54
 This may be relevant and applicable to the 
childhood obesity problem in North America as these findings illustrate how the early 
nutritional conditions among low income families in general may contribute to the 
development of overweight and obesity. 
During infancy, rapid increases in weight but normal growth in length or height has been 
shown to be associated with obesity risk in childhood.
55-57
 The pertaining literature 
defines rapid infancy weight gain in various ways. A review of several papers examined 
the impact of rapid weight gain in the first two years of life on later obesity risk using 
standardized scores for change in weight over each year and defining rapid weight gain as 
any z-score change greater than 0.67.
55
  This review concluded a positive association 
between rapid weight gain in the first two years of life and childhood obesity, 
independent of weight at birth.
55
 Another study examined the impact of rapid weight gain 
in the first 4 months of life on overweight status at 7 years of age, measuring weight gain 
as a continuous rate of change in weight per 100 grams per month.
57
 This study found 
that independent of weight achieved by the first year, the rate of weight gain in the first 4 
months was positively associated with overweight at 7 years of age.
57
 In fact, it has been 
shown that regardless of the criteria for rapid growth, the age range in which rapid 
growth is measured, or the age at outcome evaluation, rapid weight gain during infancy is 
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a significant predictor of later overweight and obesity.
56
 
Rates of weight gain in early childhood have also been shown to predict later obesity.
59
  
The timing of accelerated weight gain that leads to adolescent obesity has been shown to 
differ between males and females.
59
 When weight gain trajectories were compared within 
a large group of adolescent girls, it was found that overweight individuals exhibited 
steeper weight gain between the ages of 3 and 4 years than their normal weight 
counterparts.
59
 A similar pattern was found among overweight adolescent boys, except 
accelerated weight gain occurred between the ages of 5 and 8 years.
59
  For both females 
and males, growth in height remained similar between overweight and normal weight 
individuals.
59
 This indicates that steep weight gain occurring during these early stages 
can serve as an early warning sign for later obesity. 
Early growth patterns also have important implications for adult morbidity.
58 60
 A large 
longitudinal study examined the impact of rates of weight gain in childhood on 
subsequent risk of coronary heart disease, type 2 diabetes, and hypertension in 
adulthood.
58
 It was found that individuals who were small at birth or at 1 year of age and 
subsequently experienced rapid weight gain between the ages of 3 and 11 years were at 
highest risk for all three chronic conditions.
58
 Another study found similar patterns of 
early growth that significantly increased risk of type 2 diabetes.
60
 High birth weight, 
defined as greater than 3.5 kilograms, followed by steep growth in weight but not height 
between the ages of 2 and 12 years was associated with type 2 diabetes in later life.
60
 
Additionally it was found that the highest incidence of type 2 diabetes at age 40 years 
occurred among individuals who had high birth weight and subsequent stunted growth in 
length during the first 3 months of life.
60
  
Timing of Adiposity Rebound 
As previously discussed, particular patterns of weight gain within the first few years of 
life are associated with risk of obesity and later morbidity.
61-67
  The timing of these early 
growth patterns also has important consequences for BMI in later childhood and early 
adulthood.
64-66
 In typical development, after an initial decline in body fatness in the first 
years of life, the body regains fat at a consistent rate throughout childhood and into 
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adulthood.
65
 The point at which the renewed incline in body fatness occurs has been 
termed the adiposity rebound (AR).
64
 Studies have shown that the timing of this 
developmental event is an important predictor of later obesity.
61 64-66
  
Earlier than average occurrence of AR is associated with increased risk of overweight 
and obesity in childhood,
66
 adolescence,
64
 and adulthood.
65
  In fact, individuals who 
experience early AR are reportedly 6 times more likely to be obese as adults than 
individuals who experience normal or late AR.
65
  This relationship has been shown to 
persist even after adjustment for BMI at the time of AR as well as adjustment for parental 
BMI.
65
 Even among infants who are obese by 1 year of age, those who experience later 
AR have been shown to attain normal BMI by the age of 16 years while individuals who 
have early AR remain overweight into adolescence and early adulthood.
64
   
Early AR has specifically been associated with increased fat mass.
66
 Indeed, one study 
combined measures of triceps and subscapular skinfolds into a fat mass index and found 
that early AR was significantly associated with higher fat mass index scores.
66
 The same 
study found that waist circumference at 26 years of age was also significantly associated 
with early AR.
66
 Among overweight and obese individuals, the relative risks of waist 
girth exceeding international cut-offs were 2.12 and 3.32, respectively, comparing 
individuals who experienced early AR to those who experienced late AR.
66
 These 
findings indicate the ability of the timing of AR to act as an even more sensitive indicator 
of unhealthy fat mass than BMI, which can only approximate overall body fat. 
It has been reported that early AR is associated with adult morbidity, specifically in terms 
of glucose tolerance.
67
 One study showed that among adults aged 26 to 32 years, those 
who experienced early AR were most likely to suffer from diabetes or other forms of 
IGT.
67
 This relationship was demonstrated despite the fact that BMI at the time of AR 
was within normal ranges and similar to individuals who had normal glucose tolerance in 
adulthood, suggesting that the timing of AR was the main predictor of later glucose 
tolerance disorders.
67
  
It is evident that childhood obesity is a complex health issue that requires a more nuanced 
approach to its analysis as a health outcome in epidemiological study. The purpose of 
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preventing overweight and obesity in childhood is to prevent childhood and adult disease. 
Thus, it is important to examine other weight-related phenomena that may act as more 
sensitive warning signs for later obesity-related metabolic disease, such as the adiposity 
rebound. Indeed, the importance of examining growth trajectories in order to properly 
capture the entire phenomenon of childhood obesity is indisputable.  
1.4 Early Influences on Childhood Weight Gain 
The question that has not yet been addressed in this discussion is, of course, what causes 
childhood obesity? This is particularly complicated to answer since causality can only be 
examined if a causal factor precedes a particular outcome. In the case of childhood 
obesity, it is often difficult to determine the exact timing of onset. Indeed, as previously 
discussed, the developmental processes that lead to childhood overweight and obesity are 
already evident in infant growth patterns. An emergent avenue of research on the etiology 
of childhood overweight and obesity is one that focuses on risk factors present in the 
perinatal environment. In terms of causality, risk factors present prior to or shortly after 
birth can indeed be concluded to precede the outcome. Hence, examining perinatal risk 
factors can reveal more clues about the causes and development of childhood overweight 
and obesity.  
1.4.1 Maternal Prenatal Characteristics, Behaviours, Diet, and 
Health 
It has been suggested that maternal age, particularly very young or advanced maternal 
age, is associated with extremes of neonatal weight.
68 69
 In terms of the low weight end of 
the spectrum, infants born to adolescent or advanced age mothers are at greater risk of 
low birth weight.
68 69
 There is also evidence that primiparity is associated with low birth 
weight.
70
 Interestingly, low weight babies born to primiparous mothers have been shown 
to demonstrate subsequent catch-up growth that results in children being heavier and 
taller than their peers.
70
   
A similar pattern of low birth weight and subsequent catch-up growth and childhood 
overweight has been demonstrated in cases where mothers smoked during pregnancy.
70-72
 
Children born to mothers who smoked during pregnancy have been shown to be 
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significantly smaller for gestational age, that is they have lower birth weight and birth 
length, than children born to non-smokers.
70
 However, smoking during pregnancy has 
also been associated with later childhood overweight and obesity despite causing initial 
low weight.
70-72
 Indeed, a dose-response relationship has been shown between number of 
cigarettes smoked during pregnancy and risk of overweight and obesity in childhood.
71 72
  
Several studies have reported that maternal diet during pregnancy, which directly impacts 
the prenatal nutritional environment, can impact later weight status of offspring.
5 73
  
Indeed, one retrospective cohort study showed that exposure to famine during pregnancy 
is linked to later obesity in children born to undernourished women.
73
 Similarly, animal 
studies have demonstrated that permanent programming of accelerated fat tissue growth 
occurs as a result of maternal nutrient imbalance during gestation.
5
 
Maternal health complications during pregnancy have been shown to impact later 
offspring weight and growth patterns. Gestational hypertension has been linked to an 
increased risk of high birth weight and large size for gestational age,
74
 both of which have 
been shown to predict subsequent childhood overweight and obesity.
44 46 48 49 51
 There is 
also strong evidence for the association between maternal glucose tolerance disorders 
during pregnancy and offspring weight at birth and childhood weight. Indeed, various 
forms of IGT during pregnancy have been shown to increase the risk of later adiposity in 
offspring.
15 75-93
  
1.4.2 Fetal Growth and Early Nutrition  
Fetal growth and postnatal nutrition have also been shown to impact later childhood 
weight status.  Birth weight for gestational age has been shown to be a more important 
indicator of later childhood growth patterns and health than absolute birth weight. In fact, 
it is when birth weight is abnormal for gestational age that effects on later childhood 
growth and weight are evident. Children who are born LGA often become heavier on 
average in childhood.
94
 Being born small for gestational age (SGA) has also been shown 
to have lasting effects on growth in early childhood. Indeed, it has been shown that 
children born SGA are smaller on average by the age of 4 years than their AGA peers.
94
 
There is also evidence that both advanced maternal age and primiparity are associated 
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with increased risk of SGA infants.
95-98
 
In terms of postnatal nutrition, many studies have demonstrated that whether infants are 
breastfed at all,
99-104
 duration and consistency of breastfeeding,
46 99 101 105-110
 and timing of 
the introduction of solid foods
111
 all have a significant impact on later obesity risk.  
Indeed, most studies examining the effect of breastfeeding on infant, childhood, and 
adolescent weight that have had significant findings report a reduced risk of obesity 
associated with breastfeeding. It has been suggested that longer duration of breastfeeding 
may protect high risk children, for example those born LGA, from developing obesity.
104 
108
 In particular, a few studies have found that the association between prolonged 
breastfeeding and lowered obesity risk is particularly pronounced among children born to 
overweight and obese mothers.
107 112
 One study further showed that prolonged 
breastfeeding coupled with delayed introduction of solid foods is associated with reduced 
odds of obesity and increased probability of healthy weight status at age 2 to 4 years.
111
  
1.5 Gestational Diabetes Mellitus 
The focus of the current study is the association between prenatal exposure to GDM and 
BMI trajectories in early childhood. This is particularly relevant since worldwide, the 
prevalence of GDM among women has reportedly been growing. Increasing trends in 
GDM prevalence raise many population health concerns. By definition, GDM may be a 
temporary state of glucose intolerance that resolves after delivery.  However, in some 
cases glucose intolerance may persist postpartum.  Indeed, many studies have reported a 
much higher risk of subsequent diabetes mellitus among women with GDM compared to 
women with a normal pregnancy.
113-118
 Thus, increasing trends in prevalence of GDM 
may predict similarly increasing trends in diabetes mellitus among parous women.   
Increasing GDM prevalence has important health implications for children, since 
offspring from pregnancies complicated by GDM often have poor health outcomes.  The 
association between forms of maternal IGT during pregnancy, including GDM, on 
offspring weight has been extensively studied. In particular, prenatal exposure to GDM is 
a known and common cause of fetal macrosomia,
119
 which has been shown to be an 
important predictor of childhood obesity.
45-53 120
  Overweight and obesity in childhood 
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and adolescence have also been linked to prenatal exposure to GDM.
76 83 121
 Although 
GDM is also associated with high maternal pre-pregnancy BMI, it has been found that 
the effects of GDM on offspring weight status may be independent of maternal pre-
pregnancy BMI.
80
 Thus, an increasing trend in GDM prevalence has important 
implications for the childhood obesity epidemic.   
1.5.1 Trends in Prevalence of Gestational Diabetes Mellitus 
An increasing prevalence of GDM among women in various populations worldwide has 
been documented by a number of studies.
122-129
  In regions across North America, the 
prevalence of GDM has increased by approximately 60–120% over two decades.122 124  
More recently, over the last ten years GDM prevalence has increased by approximately 
30–180% in different global populations.125-127  In Canada, there have also been 
indications of increasing trends in GDM prevalence.
122 127
 One study that investigated 
trends in GDM prevalence in Manitoba over a twenty-year period reported a 60% 
increase in GDM prevalence from 1985 to 2004.
122
 Another study by Davenport and 
colleagues
127
 observed GDM prevalence over a ten-year period in London, Ontario and 
reported a 45% increase in prevalence from 2000 to 2009.
127
 These trends suggest the 
possibility of increasing GDM prevalence across Canada.  
One important factor to consider when examining the trends in prevalence of GDM in 
Canada and around the world is changes in diagnostic criteria over time.  The Society of 
Obstetricians and Gynaecologists of Canada implemented the first national GDM 
screening guidelines in 1992.
122
 These new guidelines required universal GDM screening 
for all pregnant women in the 24th to 28th week of pregnancy.
122
  Following this, the 
only major changes to guidelines were made in 1998 by the Canadian Diabetes 
Association, which suggested different diagnostic criteria for glucose tolerance test 
results.
122
   
Due to these changes in screening guidelines and diagnostic criteria for GDM, increasing 
trends in GDM prevalence in Canada after 1992 may be attributable to the 
implementation of universal screening.  Similarly, trends before and after 1998 would 
need to be examined against changes in diagnostic criteria.  However, since 1998 there 
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have been no substantial changes in screening guidelines and diagnostic criteria.  Thus, 
trends in GDM prevalence in Canada during the past decade likely reflect true changes in 
GDM incidence over time.  Indeed, the 45% increase in GDM prevalence in London, 
Ontario reported by Davenport et al.
127
 occurred during a period when there were no 
changes in GDM screening guidelines or diagnostic criteria.   
1.5.2 Factors Associated with Gestational Diabetes Mellitus Risk 
Maternal Body Mass Index 
One risk factor for GDM that has been well established is high pre-pregnancy BMI.
130
 
Torloni and colleagues
130
 conducted a meta-analysis of 70 studies examining over 
600,000 women and found that risk of GDM is strongly positively correlated with high 
pre-pregnancy BMI.  Indeed, they found that the risk of GDM increased significantly 
with increasing pre-pregnancy weight, with overweight women being twice as likely and 
obese women being more than five times as likely to have GDM compared to women 
who had normal pre-pregnancy BMI.
130
  Further, they showed that women who were 
underweight were less likely to have GDM compared to women who had normal pre-
pregnancy BMI.
130
   
Maternal Ethnicity 
Previous studies have shown that trends in the increasing prevalence of GDM differ 
according to maternal ethnicity.
122 124 128 131-138
  In the United States, the prevalence of 
GDM over the past 20 years has been increasing at a significantly higher rate among 
black women compared to white women.
124
  Indeed, it was shown that the risk of 
developing GDM conferred by maternal BMI is higher in black women versus women of 
other ethnicities. Other studies in multiethnic populations have shown that there is an 
increased risk of GDM among other ethnic minorities, including Asian, Hispanic, and 
Middle Eastern women.
131 133 135
  Among Asian women, the trends in GDM prevalence 
also vary, with higher prevalence of GDM in women of Indian descent compared to 
women of Japanese or Korean descent.
134 137 138
  Other studies have compared prevalence 
of GDM in Aboriginal versus non-Aboriginal populations and found a higher risk of 
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GDM among Aboriginal women.
122 128
 
139 140
   
These trends in GDM among different ethnic groups may reflect other differences 
between the groups, such as socioeconomic conditions, diet composition, health 
practices, and habits that may affect general health. Nevertheless, it is important to note 
how stable differences between ethnic groups may be affecting observed trends.  Further, 
some studies have noted the independent effects of ethnicity on risk of GDM,
139 141
  
indicating that there may be genetic factors promoting differences in GDM prevalence 
between ethnic groups.  
Socioeconomic Factors 
Studies that have discussed the association of socioeconomic characteristics with risk and 
subsequent prevalence of GDM have considered education level, income and 
employment as potential predictors.
131 132 142-144
  One study found a higher risk of GDM 
among unemployed women as well as a difference in risk between blue-collar and white-
collar workers.
144
  The same study observed that education level was inversely correlated 
with risk of GDM.
144
  In most studies, socioeconomic level, defined for example by 
quartiles, has been identified as the strongest predictor of GDM.
132 143
  Indeed, a large, 
multiethnic study in Australia found that socioeconomic status was inversely correlated 
with risk of GDM consistently across ethnic groups.
132
   
Maternal age 
A large number of studies have shown that the risk of GDM is associated with advanced 
maternal age.
95 122 125 131 132 139 141 145-148
 Across studies, reported risks also appear to 
increase with increasing maternal age. One study that examined pregnant women with 
ages ranging from 19 to 27 years found that women aged 25 years or older were twice as 
likely to have GDM compared to all women under the age of 25 years.
145
 Another study 
that looked at older women reported that maternal age greater than 40 years was 
associated with 6 times the risk of GDM compared to women aged 20 years or 
younger.
132
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Parity 
Studies have shown that number of past pregnancies is also associated with increased risk 
of GDM.
149 150
 Multiparity was found to be a significant risk factor for GDM among 
women in a large study examining the epidemiology of GDM among Native 
Canadians.
149
 Another study showed that there is an increasing risk of GDM with the 
increasing number of past pregnancies complicated by GDM.
150
 Indeed, women with one 
previous pregnancy complicated by GDM were 13 times more likely to have GDM than 
women who had a normal past pregnancy.
150
  
1.5.3 Challenges in Examining Gestational Diabetes Mellitus in 
Population Studies 
There are arguments that epidemiological studies examining GDM at the population level 
are faced with important methodological issues.  The main issue is that determining the 
prevalence of GDM using population data is complicated by the clinical definition of 
GDM itself.
151
  Since GDM is defined as either the onset or first recognition of glucose 
intolerance during pregnancy,
10 
 it is possible that a number of cases of GDM from 
population data may truly reflect populations of women with undiagnosed diabetes 
mellitus existing prior to pregnancy.
151
  This is particularly true for younger women who 
are less likely to be screened for diabetes prior to pregnancy.
151
 This issue is addressed by 
highlighting that the motivation for this study is the potential impact of a prenatal 
hyperglycemic environment caused by GDM on BMI throughout childhood.  In this 
context, the current definition of GDM is acceptable given that the risk posed by GDM is 
through prenatal exposure to elevated maternal blood sugar levels due to the absence of 
previous diabetes diagnosis and thus the absence of treatment at initial stages of 
pregnancy.
80 81 88 93
 Thus, whether or not a GDM diagnosis reflects maternal glucose 
intolerance that manifested during pregnancy or was present prior to pregnancy does not 
alter the exposure as defined in the current study.    
1.6 Gestational Diabetes Mellitus and Child Weight 
The current study was motivated by a growing body of evidence for the association 
between maternal IGT during pregnancy, specifically GDM, and offspring overweight or 
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obesity in infancy,
75-77 89
 childhood,
15 75 78-87 92 93
 adolescence,
78 81 88 90
 and even 
adulthood.
85 86
 Past studies providing evidence for these associations are summarized in 
table format in Appendix A. The possibility that a prenatal environment altered by GDM 
can cause permanent metabolic changes that promote development of obesity suggests 
the potential for implementation of childhood obesity prevention strategies during the 
perinatal period.  
The biological mechanisms underlying the association between prenatal exposure to 
GDM and child weight are difficult to elucidate for a number of reasons. Arguably the 
most important barrier to understanding how maternal IGT may influence child obesity is 
the difficulty in producing evidence that this association exists independent of important 
confounding factors such as maternal pre-pregnancy BMI and genetic predisposition. 
However, a few studies offer compelling evidence that this association does exist.  
Indeed, studies of siblings with discordant intrauterine exposure to maternal IGT,
79
 
studies examining maternal versus paternal IGT,
79
 and studies of prenatal exposure to 
maternal IGT that control for other important risk factors for child obesity such as 
maternal BMI
80
 support the notion that the association between maternal IGT and child 
weight is likely due to environmental rather than genetic factors.   
One study strongly supports the role of intrauterine exposure to maternal IGT rather than 
genetic predisposition in subsequent risk of overweight and diabetes in offspring.  This 
was a study done by Dabelea and colleagues
79
 that examined siblings of the same parents 
who were discordant for prenatal exposure to maternal IGT, with at least one sibling born 
before and at least one sibling born after maternal diabetes diagnosis. Among families in 
which none of the children had diabetes, it was found that siblings born after their mother 
was diagnosed with diabetes had significantly higher BMI than their siblings born prior 
to the diagnosis at a similar age.
79
 Analyses controlling for sibship revealed that although 
siblings who were exposed to maternal diabetes in utero initially had lower BMI at the 
ages of 6 to 9 years, after 9 years of age these siblings had BMI that was on average 2.6 
kg/m
2
 higher than their siblings who were not exposed to maternal diabetes prenatally at 
a similar age.
79
 Further supporting the importance of intrauterine exposure to diabetes 
over genetic predisposition, this study showed that among families in which at least one 
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sibling had diabetes, the risk of diabetes was almost 4 times greater for siblings born after 
maternal diagnosis of diabetes. Even more compelling was the finding that the timing of 
paternal diabetes diagnosis had no significant effect on either BMI or the risk of diabetes 
among siblings.
79
 Taken together, these findings support the notion that, independent of 
genetic factors, maternal IGT exerts an important effect on the prenatal environment that 
has a lasting impact on later offspring growth and metabolism.  
The environmental or epigenetic mode of impact of maternal hyperglycemia during 
pregnancy has also been demonstrated in animal studies done by Dörner, Plagemann, and 
colleagues.
11 152 153
 These studies demonstrated that artificially induced gestational 
diabetic rat mothers gave birth to offspring who exhibited overweight, overeating, IGT, 
and hyperinsulinemia. Not only did offspring acquire these abnormal metabolic patterns 
through artificially induced changes to the prenatal environment, these changes were 
passed on epigenetically to the next generation through the female offspring, despite 
mating with healthy males.
11
 Indeed, unlike their mothers, the first generation of female 
offspring exhibited spontaneous (i.e., not artificially induced) gestational diabetes during 
their pregnancies that resulted in the same abnormal metabolic patterns as the original 
offspring.
11
 These studies provide a strong case for the environmental or epigenetic 
action of maternal IGT during pregnancy.  
1.6.1 Proposed Biological Mechanisms 
This assertion that maternal IGT during pregnancy can result in changes to the prenatal 
environment that alter offspring growth and metabolism is supported by biological 
theories. One popular theory explains that changes in offspring growth in response to a 
hyperglycemic prenatal environment occur through over-nutrition, which results in fetal 
overgrowth, macrosomia at birth, and subsequent overweight and obesity.
15
 This theory 
further goes on to suggest that intrauterine exposure to maternal hyperglycemia results in 
permanent changes in offspring metabolic response that increase postnatal risk of 
overweight and obesity.
12 13
 Thus, according to this theory, not only does intrauterine 
exposure to maternal hyperglycemia during pregnancy result in fetal overgrowth and 
overweight in neonatal life, it results in changes that maintain overweight throughout life. 
22 
 
The causal mechanisms linking maternal hyperglycemia to both fetal overgrowth and 
permanent changes in offspring metabolic response occur through fetal hyperinsulinemia. 
Exposure to maternal hyperglycemia in utero results in a fetal regulatory response to 
increase insulin production, thereby creating a state of fetal hyperinsulinemia. Insulin in 
the prenatal environment is known to have growth-promoting properties, and in high 
concentrations can cause teratogenic effects that result in macrosomia or enlargement of 
internal organs.
11 14
 The association between fetal hyperinsulinemia and permanent 
changes in offspring metabolic response has been demonstrated by Plagemann and 
colleagues
13
 through an animal model. In their study, rat mothers were either artificially 
induced to have GDM or given a placebo treatment. Plagemann and colleagues found that 
offspring of GDM rat mothers exhibited hyperinsulinemia, which was associated with 
elevated levels of two neurotransmitters that stimulate food intake, neuropeptide Y and 
galanin.
13
 Since insulin is able to cross the blood-brain barrier and alter the activity of 
these neurotransmitters,
154 155
 it is theorized that hyperinsulinemia occurring at critical 
stages in fetal development may permanently alter this neural regulatory system.
11 13
 A 
permanently altered neural system that normally regulates appetite and food intake has 
obvious consequences for postnatal weight gain. Indeed, Plagemann and colleagues have 
shown that hyperphagia, or overeating, and overweight were consequences of this 
observed causal mechanism among rat offspring.
11
 
The most compelling finding from the studies done by Plagemann and colleagues
11
 was 
that permanent malprogramming of the neural regulatory system for food intake caused 
by fetal hyperinsulinemia was entirely preventable through adequate control of maternal 
hyperglycemia during pregnancy in rat mothers. Thus, there is biological evidence that 
maternal IGT during pregnancy exerts effects on offspring that are directly associated 
with later weight and weight gain.  Further, these findings indicate that the mechanisms 
by which maternal IGT affect offspring growth and metabolism indeed act through 
maternal blood glucose concentration. 
1.6.2 GDM and Birth Weight  
In Section 1.3.2 the association between high birth weight or macrosomia and subsequent 
overweight and obesity in childhood was discussed. As the theories of the biological 
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mechanisms linking maternal IGT to offspring growth and metabolism suggest, prenatal 
exposure to maternal hyperglycemia can result in fetal overgrowth and high birth weight. 
Indeed, a number of studies have shown that high birth weight for gestational age is 
associated with prenatal exposure to various forms of maternal IGT during pregnancy.
76 
77 82 85 89
 Although high birth weight has been linked to maternal overweight, several of 
these studies clearly support the independent relationship between intrauterine exposure 
to maternal hyperglycemia and subsequent high birth weight.  
Buzinaro and colleagues
76
 found that women diagnosed with GDM gave birth to infants 
with significantly higher birth weight than women without a GDM diagnosis who either 
exhibited some gestational hyperglycemia or normal glucose tolerance. Notably, women 
in their study with GDM had significantly higher fasting and daily blood glucose 
concentrations than women with some hyperglycemia or normal glucose tolerance 
despite that the three groups of women did not differ in age, pre-pregnancy BMI, or 
weight gain during pregnancy.
76
 Another study that examined the risk of macrosomia 
according to maternal plasma glucose concentration during the third trimester of 
pregnancy found a significant linear trend between increasing plasma glucose 
concentration and increasing frequency of macrosomia, even after exclusion of women 
who had relative body weight in excess of 119% to normal body weight.
89
 Among 
women with mild GDM in an Australian study done by Gillman and colleagues,
82
 
random assignment to an intervention that involved monitoring and management of blood 
glucose through dietary counselling and insulin therapy when needed was associated with 
a decrease in prevalence of macrosomia by almost 75% compared to a routine care 
group.
82
  
1.6.3 GDM and Childhood Weight 
The body of evidence for the association between maternal IGT during pregnancy and 
childhood weight is vast and continues to grow as the current obesity epidemic generates 
more interest in the prenatal origins of childhood overweight and obesity.
15 75 76 78-88 90 92 93
 
Studies examining the impact of intrauterine exposure to maternal IGT on childhood 
adiposity between the ages of 1 and 3 years have shown evidence of increased adiposity 
associated with maternal IGT during pregnancy.
75 80 91 92
 However, some studies 
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examining very young children only found significant differences between those who 
were exposed to maternal IGT in utero and those who were unexposed when adiposity 
was measured by direct measures of body fat (i.e., skinfold thickness) rather than indirect 
measures (i.e., BMI),
92
 while others were able to show differences using both types of 
measures.
91
  
Evidence for the association between maternal IGT during pregnancy and childhood 
adiposity appears to become more complicated when studies examine weight outcomes in 
later childhood. In the previously mentioned Australian study done by Gillman and 
colleagues,
82
 in which mothers with mild GDM were randomly assigned to routine care 
or an intervention to manage blood glucose during pregnancy, recorded data on 
children’s height and weight at ages 4 to 5 years were also analysed. Although children 
born to mothers who were given routine care had higher incidence of macrosomia, by the 
ages of 4 to 5 years this study found no significant differences in BMI between the 
groups.
82
 A different study done by Lee and colleagues
84
 examined two groups of women 
with different levels of hyperglycemia during pregnancy, one group with diagnosed 
GDM and one group defined as having a milder form of IGT during pregnancy. Women 
in the study with diagnosed GDM exhibited higher blood glucose levels than women with 
IGT. Interestingly, the study found no significant differences in child BMI measured at 
the ages of 3 to 4 years. However after the age of 5 years, children of mothers with GDM 
had significantly higher BMI than children of mothers with mild IGT.
84
 These findings 
seem to suggest that the two studies were capturing different stages of the same 
phenomenon and that the impact of intrauterine exposure to maternal hyperglycemia may 
continue to have important effects on adiposity throughout childhood. 
Despite this large body of evidence, interpreting the literature as a whole is complicated 
as offspring weight outcomes are evaluated at many different stages in childhood, 
adolescence, and adulthood depending on the availability of data in any given study. As a 
result, different studies have reported associations between maternal IGT during 
pregnancy and offspring adiposity at 1 year of age
91
 up to 19 years of age
85
 as well as 
many increments in between. One can speculate about the phenomenon linking maternal 
IGT during pregnancy to adiposity throughout childhood by considering studies that 
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examine adiposity at adjacent time points in childhood together such as the Gillman et 
al.
82
 and Lee et al.
84
 studies. However differences in study design would inevitably result 
in erroneous conclusions. Further complicating the matter of summarizing the overall 
evidence for the association between maternal IGT during pregnancy and adiposity 
throughout childhood, different studies measure adiposity in various ways. These include 
different measures, such as direct and indirect measurements, as well as different cut 
points for defining overweight and obesity.  
1.7 Summary 
Determining the prenatal origins of childhood overweight and obesity is becoming ever 
more important in light of the increasing prevalence of childhood obesity in Canada and 
around the world. Although a number of studies have suggested that prenatal exposure to 
GDM is a predictor of obesity status in childhood, there is a lack of research dedicated to 
how GDM exposure may be impacting childhood growth trajectories. 
76 83 121
  
Furthermore, the few studies that have considered the impact of GDM exposure on BMI 
at different time points throughout childhood do not model growth data continuously 
from infancy throughout childhood.
75 156
 Later morbidity associated with overweight and 
obesity is not necessarily predicted by weight status at a single point in time,
39
 but rather 
by patterns of growth.  Thus when establishing whether risk factors such as GDM are 
causally related to overweight and obesity in childhood, it is important to examine the 
effects of these factors on trajectories of growth. 
This thesis takes the important next step for the research on the prenatal origins of 
childhood obesity by examining the effect of an important risk factor for childhood 
overweight and obesity on childhood BMI trajectories. The role of intrauterine exposure 
to GDM in shaping early childhood BMI trajectories may reveal the mechanisms by 
which this risk factor can lead to later childhood overweight and obesity and also guide 
early obesity prevention strategies.  
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Chapter 2  
2 Objectives and Hypothesis 
2.1 Objectives 
The main purpose of this thesis is to examine the association between prenatal exposure 
to GDM and early childhood BMI trajectories modelled continuously from infancy 
through early childhood. The study population was derived from the National 
Longitudinal Survey of Children and Youth (NLSCY), described in the next chapter. The 
three specific objectives are summarized below. The sub-sections that follow provide 
detailed rationale for each objective. 
Objective 1 
Examine the direct effect and indirect effect (through birth weight for gestational age) of 
prenatal exposure to GDM on BMI trajectories of Canadian children aged 2 to 10 years 
who participated in the NLSCY. 
Objective 2 
Assess whether the direct effect and indirect effect (through birth weight for gestational 
age) of prenatal exposure to GDM are partially explained by maternal demographic, 
lifestyle, and socioeconomic characteristics including age, parity, highest level of 
education achieved, smoking during pregnancy, and income adequacy for the household.  
Objective 3 
Assess whether the direct effect and part of the indirect effect (i.e., the pathway leading 
from birth weight for gestational age to childhood BMI trajectories) of prenatal exposure 
to GDM on childhood BMI trajectories differ between children who were not breast fed 
and children who were breast fed.  
2.1.1 Objective 1 
Based on the proposed theories of the biological mechanisms linking prenatal exposure to 
GDM with overweight and obesity in childhood,
12 13 15
 the first objective was to assess 
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both direct effects of GDM on early childhood BMI trajectories as well as the indirect 
effect through birth weight for gestational age. The indirect effect reflects the fetal over-
nutrition theory that maternal hyperglycemia during pregnancy, and subsequent fetal 
hyperinsulinemia, causes fetal overgrowth that leads to high birth weight and overweight 
and obesity in childhood.
15
 The direct effect reflects all other potential causal 
mechanisms linking prenatal exposure to GDM with childhood BMI trajectories. One 
theory that can account for this effect posits that exposure to maternal hyperglycemia in 
utero results in permanently reduced sensitivity to hormones that regulate appetite and fat 
cell growth, which increases the risk of later development of obesity.
12 13
 These 
hypothesized causal mechanisms are summarized in Figure 2.1.  
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Figure 2.1. Causal model for Objective 1. Hypothesized association between prenatal 
exposure to GDM and childhood BMI trajectories 
2.1.2 Objective 2 
A number of factors that are associated with GDM diagnosis are also causally related to 
birth weight for gestational age as well as childhood BMI trajectories. Thus, confounding 
by these other factors needs to be addressed. The most notable confounder for the 
association between prenatal exposure to GDM and childhood BMI trajectories is 
maternal pre-pregnancy BMI. However, questions regarding maternal weight prior to and 
during pregnancy were not asked in the NLSCY and thus the current study was unable to 
control for this important confounder. To approximate the conditions in which maternal 
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and childhood overweight and obesity may arise and to account for other factors 
associated with GDM risk, various lifestyle, demographic, and socioeconomic factors 
that were available in the NLSCY were included in this analysis. Thus the second 
objective was to assess whether maternal and lifestyle characteristics such as age, parity, 
highest level of education achieved, smoking during pregnancy, and household income 
adequacy partially explain the observed association between prenatal exposure to GDM 
and childhood BMI trajectories. The adjusted causal model for Objective 2 is shown in 
Figure 2.2 below. 
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Figure 2.2. Causal model for Objective 2. The direct and indirect effects of prenatal 
exposure to GDM on childhood BMI trajectories adjusted for maternal demographic (age, 
parity), lifestyle (smoking), and socioeconomic characteristics (highest level of education 
achieved, income adequacy for the household). 
 
2.1.3 Objective 3 
The final objective is to assess whether the nature of the direct effect and indirect effect 
(through birth weight for gestational age) of prenatal exposure to GDM on childhood 
BMI trajectories differ by breastfeeding initiation/non-initiation (Figure 2.3). 
Modification of the association between prenatal exposure to GDM and early childhood 
BMI trajectories by breastfeeding initiation/non-initation is of particular interest since 
studies have suggested that breastfeeding may be a protective factor against development 
of childhood obesity. Specifically, breastfeeding has been shown to reduce the risk of 
childhood obesity despite the presence of early life risk factors, for example macrosomia 
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at birth. Examining whether the effects of prenatal exposure to GDM on childhood BMI 
trajectories differ according to breastfeeding initiation/non-initiation is further justified as 
breastfeeding may be a potential avenue for the prevention of child overweight associated 
with prenatal exposure to GDM.  
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Figure 2.3. Causal model for Objective 3. The adjusted direct and indirect effects of 
prenatal exposure to GDM on childhood BMI trajectories are modified by breastfeeding.  
 
2.1.4 Stratifying Analyses by Sex 
Due to the a priori expectation that female and male children are essentially two distinct 
populations that have different patterns of growth throughout childhood, all analyses are 
stratified by sex. Since the indirect effect of prenatal exposure to GDM is mediated by 
birth weight, and on average males have higher birth weight than females,
157
 it is 
necessary to separate analyses by sex. The results of stratified analyses may reveal effect 
modification by sex of the direct effect and/or indirect effect of prenatal exposure to 
GDM on childhood BMI trajectories. However, there are no explicit hypotheses about the 
differences between females and males in terms of either the direct effect or indirect 
effect through birth weight for gestational age of prenatal exposure to GDM on childhood 
BMI trajectories.  
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2.2 Hypotheses 
Objective 1 
It is hypothesized that children who were exposed to GDM prenatally will have higher 
BMI at 2 years of age compared to their unexposed peers. It is also hypothesized that the 
rate of increase in BMI between the ages of 2 and 10 years will also be higher among 
children who were exposed to GDM prenatally than their unexposed peers. These two 
explicit hypotheses about the effects of prenatal exposure to GDM on initial BMI (at age 
2 years) and the rate of increase in BMI throughout childhood are contingent on the 
hypothesis that prenatal exposure to GDM acts through the direct and/or indirect 
pathways. Therefore, it is also expected that the results for either the direct pathway 
between prenatal exposure to GDM and childhood BMI trajectories or the indirect 
pathway through birth weight for gestational age, or both, will be significant.    
Objective 2 
Statistical control for maternal demographic, lifestyle, and socioeconomic factors is 
expected to attenuate the associations between prenatal exposure to GDM and childhood 
BMI trajectories. Taken together, maternal age, parity, highest level of education 
achieved, smoking during pregnancy, and household income adequacy are hypothesized 
to act in the mediated causal pathway by predicting GDM diagnosis and thus prenatal 
exposure to GDM, as well as birth weight for gestational age and childhood BMI 
trajectories. As previously discussed, maternal age and parity are associated with both the 
risk of GDM as well as child weight outcomes. Smoking is also correlated with GDM
148
 
and is a predictor of childhood overweight and obesity.
71 72
 Maternal education and 
household income adequacy are socioeconomic factors that are also associated with both 
risk of GDM and childhood weight status. Socioeconomic status is also a well established 
predictor of adult obesity, and thus maternal education and household income adequacy 
also act as proxy variables for maternal obesity.  
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Objective 3 
Breastfeeding is expected to modify the association between prenatal exposure to GDM 
and early childhood BMI trajectories. Specifically, it is hypothesized that the magnitude 
of the direct effect and the partial indirect effect (i.e., the pathway from birth weight for 
gestational age to childhood BMI trajectories) of prenatal exposure to GDM on childhood 
BMI trajectories from Objective 2 will be reduced for children who were breastfed 
compared to children who were never breastfed. Thus, it is expected that breastfeeding 
will attenuate the association between prenatal exposure to GDM and childhood BMI 
trajectories. 
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Chapter 3  
3 Methods 
This chapter outlines the secondary data analysis that was conducted in the current study, 
beginning with a description of the data source (Section 3.1) followed by a description 
and discussion of the treatment of measurement instruments used in analyses (Section 
3.2).  The next section gives an overview of the analytic technique used in the current 
study, latent growth curve modelling (Section 3.3). Section 3.4 discusses some model 
considerations, covering the issues of time scores (Section 3.4.1), model fit (Section 
3.4.2), and missing data (Section 3.4.3). The final section details the analyses that were 
done to address each of the research objectives (Section 3.5). 
3.1 Data Source 
This study analysed the longitudinal component of the National Longitudinal Survey of 
Children and Youth (NLSCY).  This dataset was accessed through the Statistics Canada 
Research Data Centre at Western University following approval of a peer-reviewed 
application for data access. The survey was designed by Human Resources Development 
Canada and conducted by Statistics Canada to measure child development and well-being 
with the intention of creating a national database of characteristics and experiences of 
Canadian children and youth from infancy to adulthood. The NLSCY sampling design 
involved both cross-sectional and longitudinal components. Beginning in 1994, data from 
a nationally representative longitudinal cohort of children, initially aged 0 to 11 years, 
were collected biennially. In addition to the longitudinal sample, cohorts of children aged 
0 to 1 year were added at each cycle.  Data were collected biennially from these children 
until the age of 5 years for the purpose of monitoring development in early childhood. 
This study used data exclusively from the longitudinal cohort, specifically from cycles 2 
through 6 for children who were 2 to 3 years of age in cycle 2. The description of the 
study population is elaborated in Section 3.1.3.  Cycle-specific data files were linked 
using unique child identification numbers and combined to form a single longitudinal 
dataset for analyses.  
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3.1.1 Content of the NLSCY 
The main objectives of the NLSCY were to collect data on the prevalence of biological, 
social, economic, and environmental factors that are predictive of child health outcomes 
and how these factors are involved in child development.  To obtain information 
pertaining to all of these objectives, data collection was administered in households and 
in schools. The household component of data collection consisted of survey instruments 
completed by the person most knowledgeable (PMK) about the child (usually the child’s 
biological mother) and when applicable, questionnaires completed by the child. 
Instruments completed by the PMK included the following: (1) a questionnaire on 
household contact information and demographic data, (2) the Parent Questionnaire, (3) 
the Child Questionnaire, and (4) the Informed Consent Questionnaire.  
The Parent Questionnaire collected information about the parent and spouse (if 
applicable) on health, maternal history, education, income, neighbourhood safety, family 
functioning, labour force, social support, and socio-demographic characteristics. The 
Child Questionnaire collected information about the child on a wide variety of subjects, 
notably health, medical and biological information, child development, temperament, 
activities, relationships, and behaviour.  The household component of data collection also 
included vocabulary tests for children who were 4 to 6 years old, reading and 
mathematical aptitude tests for children in grade 2 or higher, and self-completed 
questionnaires for children aged 10 to 13 years. The school component of the NLSCY 
included self-completed questionnaires for teachers and principals for children aged 4 to 
13 years and reading comprehension and mathematical skills tests for children in grade 2 
or higher. The current study used data collected through the Parent and Child 
Questionnaires, focusing specifically on survey questions related to maternal history, 
pregnancy characteristics, maternal health during pregnancy, and reported child weight 
and height at birth and throughout childhood.  
3.1.2 NLSCY Sampling Design 
The sampling frame for the NLSCY was the sample collected for the Labour Force 
Survey (LFS), and thus the sampling design was the stratified, multi-stage design used by 
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the LFS. The LFS aimed to collect information on a nationally representative target 
population of civilian, non-institutionalized Canadians aged 15 years or older living in 
the ten provinces. The NLSCY sample was subject to the exclusions of the LFS sampling 
design, which excluded populations living in the Yukon, Nunavut, or Northwest 
Territories as well as individuals living on First Nation reserves, full-time members of the 
Canadian Armed Forces, and inmates in institutions.   In total, individuals outside the 
LFS survey coverage represent 2% of the Canadian population aged 15 years or older. 
Furthermore, unrepresented individuals from institutions or First Nation reserves 
represent only 0.5% of children living in provinces aged 0 to 11 years. Thus the 
exclusions in the NLSCY sampling design are not a major limitation and the study results 
maintain generalizability to the Canadian population.  
The stratification design was the same for each province. The first stage of stratification 
was done by dividing each province by economic regions (ER) and employment 
insurance economic regions (EIER). The primary strata in the LFS were defined by the 
ER/EIER intersections. Within the primary strata, three types of areas were defined as 
urban, rural, and remote. Urban areas, which have the highest population densities and 
the largest census metropolitan areas were further stratified. This secondary stratification 
was done by dividing urban areas into apartment frames and area frames to account for 
representation of apartment dwellers and to minimize the impact of clusters. Urban areas 
were further divided into regular, high-income, and low density population strata and 
rural areas were stratified by population density. These formed the final strata, which 
were divided into clusters that were sampled within each stratum. Households or 
dwellings were then selected from the sampled clusters. Probability sampling was used at 
each stage of the study design. Depending on the size and type of stratum, different 
numbers of dwellings were selected. 
3.1.3 Study Population 
To model childhood BMI trajectories from age 2 to age 10 years, children included in the 
study population were required to have contributed longitudinal data and be 
approximately 2 years of age in the first cycle of data used. Longitudinal children were 
selected using assigned longitudinal flags used in the NLSCY. The study population also 
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had to consist of individuals who were asked questions about maternal health and 
pregnancy characteristics, as these questions were not mandatory for all respondents. 
Indeed, only PMK’s who were the biological mothers of children under the age of 2 years 
at the time of the interview were asked questions about the pregnancy with the child 
included in the survey. Thus the cohort of interest consisted of children who were 0 to 1 
year of age in cycle 1 (1994-1995) who entered the current study at cycle 2 (1996-1997) 
when they reached 2 to 3 years of age. Five cycles of data were used for individuals aged 
2 to 3 in 1996: cycle 2 (collected between 1996 and 1997), cycle 3 (collected between 
1998 and 1999), cycle 4 (collected between 2000 and 2001), cycle 5 (collected between 
2002 and 2003), and cycle 6 (collected between 2004 and 2005).  By cycle 6 in 2004, 
most of the children in the study population had reached 10 to 11 years of age.   
The vast majority (91.6%) of PMK’s for the study population were the biological mothers 
of the children included in the survey. The Child Questionnaire component of the 
NLSCY, from which data for the current analyses were derived, was completed by the 
PMK for the child included in the survey until children reached the age of 12 years.  
Thus, data on individuals 12 years and above were not included to ensure height and 
weight data were provided by the same respondent throughout cycles. Overall response 
rates for the NLSCY declined substantially from 1994 to 2004.  The response rates for 
children in the longitudinal cohort were 86.5% in cycle 1 in 1994 and only 57.6% by 
cycle 6 in 2004.   
3.2 Measurement Instruments 
The aim of the this study was to estimate the direct effect of prenatal exposure to GDM 
on early childhood BMI trajectories as well as the indirect effect through birth weight for 
gestational age.  A secondary focus was to determine the role of maternal age, parity, 
smoking during pregnancy, maternal education, household income adequacy, and 
breastfeeding initiation in attenuating or modifying the effects of prenatal exposure to 
GDM on childhood BMI trajectories. The following section outlines how these constructs 
were measured in the NLSCY or derived using existing variables in the NLSCY (if 
applicable) as well as how variables were used in the statistical analyses. 
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3.2.1 Prenatal Exposure to GDM 
The NLSCY captured prenatal exposure to GDM through the following question in the 
Child Component of the survey answered by the biological mother of the child included 
in the survey: “During the pregnancy with [this child] did you suffer from any of the 
following: ...Pregnancy diabetes?”  If the respondent answered “yes” to this question, the 
index child was considered to have been “exposed to GDM in utero”.  Similarly, if the 
respondent answered “no” to the above question, the index child was considered to have 
been “not exposed to GDM in utero”.  The variable for prenatal exposure to GDM was 
thus treated as a binary categorical variable in analyses.   
3.2.2 Body Mass Index 
Body mass index (BMI) at each cycle of follow-up was used to model BMI trajectories 
for children aged 2 to 10 years.  The NLSCY collected information on height and weight 
for children up to the age of 10 years at each cycle through maternal report. These 
measures were used to compute BMI scores by dividing weight in kilograms by height in 
metres squared. Prior to computing BMI, child height data were scanned for implausible 
changes in height (e.g. negative changes) and erroneous height values were corrected by 
imputing a complex average height value using surrounding data points and taking time 
of data collection into account. The imputed values were calculated as follows: 
                  
         
         
   
where hb was the height value to be corrected, ha and hc were the surrounding height 
values from which the imputed value was to be derived, ageb was the age in months at the 
time of the interview in which the erroneous height value (hb) was recorded, and agea and 
agec were the ages in months at the interviews in which the two surrounding correct 
height values (ha and hc) were recorded.  
Following computation of BMI using corrected child height data, BMI data were scanned 
for biologically implausible BMI-for-age-and-sex values using the Centers for Disease 
Control and Prevention (CDC) guidelines based on the 2000 CDC growth charts.
158
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Biologically implausible values for BMI were treated as missing values in analyses. 
3.2.3 Birth Weight for Gestational Age Z-Score 
A continuous variable for birth weight for gestational age z-score was derived using 
questions in the NLSCY about child birth weight and gestational age. PMK’s for the 
children included in the survey were asked to state the child’s birth weight in kilograms 
and grams and gestational age in days. Birth weight in kilograms and grams was 
converted to birth weight in grams. Gestational age in days was converted to gestational 
age in weeks. The z-scores were then calculated based on guidelines for birth weight for 
gestational age established by Kramer and colleagues.
159
 Briefly, Kramer et al. 
159
 used 
population-based Canadian data to derive means and standard deviations for birth weight 
in grams at each week of gestational age from 22 to 43 weeks for females and males, 
separately. These reference means and standard deviations were then used to calculate z-
scores for birth weight for gestational age through the following equation: 
   
                                     
                  
 
The z-scores were calculated for each child using the reference mean and standard 
deviation for birth weight associated with their gestational age in weeks.
159
 The birth 
weight for gestational age z-score was treated as a continuous variable in statistical 
analyses.  
3.2.4 Maternal Age 
A variable for maternal age at time of delivery was derived using questions asked in the 
NLSCY about the age of the biological mother at the time of interview as well as the 
child’s age at the time of interview.  Child’s age in years at the time of the interview was 
subtracted from the age of the biological mother in years at the time of interview to 
obtain maternal age at delivery. Maternal age was treated as a continuous variable in all 
statistical analyses.  
3.2.5 Parity 
The NLSCY includes the following question to determine parity: “How many babies 
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have you had?” Since there were no specific hypotheses regarding the number of past 
pregnancies, parity was dichotomized as primiparous (one past pregnancy) and 
multiparous (more than one past pregnancy).  Thus parity was treated as a binary variable 
in all statistical analyses.  
3.2.6 Maternal Education 
The NLSCY allocated a section in the Parent Questionnaire to collect information on 
education for the PMK.  As mentioned previously, the vast majority (91.6%) of PMK’s 
were the biological mothers of the children included in the survey. A variable for the 
highest level of education obtained by the PMK was derived in the NLSCY from the 
following questions: “Excluding kindergarten, how many years of elementary and high 
school [have you] successfully completed,” “[Have you] graduated from high school,” 
“[Have you] ever attended any other kind of school such as university, community 
college, business school, trade or vocational school, CEGEP or other post-secondary 
institution,” and “What is the highest level of education that [you have] attained?”  
The derived “recoded highest level of education obtained” variable contained information 
about years and type of schooling as well as obtained diplomas, certifications, and 
degrees.  This variable had 11 categories that were ranked in the following order:  
1. Elementary school (8 years of schooling or less) 
2. Some secondary school (9 years of schooling or more with no secondary school 
graduation) 
3. Secondary school graduation 
4. Other beyond high school 
5. Some trade school etc. 
6. Some community college etc. 
7. Some university 
8. Diploma/certificate trade school etc. 
9. Diploma/certificate community college etc. 
10. Bachelor degree (includes LLB) 
11. Masters, degree in medicine, doctorate 
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Since the categories were ranked in order of schooling level, this variable is considered to 
be ordinal. However, as the most important information for the purposes of the current 
study was contained in the ranking number, this variable was treated as a continuous 
variable in statistical analyses. 
3.2.7 Smoking During Pregnancy 
In the NLSCY smoking during pregnancy is captured in the following question: “Did you 
smoke during your pregnancy with…?” The response was binary and thus smoking 
during pregnancy was treated as a binary variable in analyses. 
3.2.8 Income Adequacy for the Household 
The variable for household income adequacy in the NLSCY was derived using 
information about total household income and number of individuals in the household. 
Level of household income adequacy was defined using five categories: lowest, lower 
middle, middle, upper middle, and highest. The lowest income adequacy category was for 
households of 1 to 4 individuals with a total income of less than $10,000 or households of 
5 or more individuals with a total income of less than $15,000. Lower middle income 
adequacy was defined as households of 1 to 2 individuals with a total income of $10,000 
to $14,999, households of 3 to 4 individuals with a total income of $10,000 to $19,999, or 
households of 5 or more individuals with a total income of $15,000 to $29,999. Middle 
income adequacy was defined as households of 1 to 2 individuals with a total income of 
$15,000 to $29,999, households of 3 to 4 individuals with a total income of $20,000 to 
$39,999, or households of 5 or more individuals with a total income of $30,000 to 
$59,999. Upper middle income adequacy was defined as households of 1 to 2 individuals 
with a total income of $30,000 to $59,999, households of 3 to 4 individuals with a total 
income of $40,000 to $79,999, or households of 5 or more individuals with a total income 
of $60,000 to $79,999. The highest income adequacy category was for households of 1 to 
2 individuals with a total income greater than or equal to $60,000 or households of 3 or 
more individuals with a total income greater than or equal to $80,000. These categories 
were used by both the General Social Survey and the National Population Health Survey. 
Since these categories were ranked in order of level of income adequacy, this variable is 
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considered to be ordinal. However, as the most important information for the purposes of 
the current study was contained in the ranking number, this variable was treated as a 
continuous variable in statistical analyses. 
3.2.9 Breastfeeding 
The NLSCY includes the following survey question for determining whether children 
were breastfed: “Did this child's mother ever breast-feed this child, even if only for a 
short time?” This question had a dichotomous response and thus breastfeeding was 
treated as a binary categorical variable in all analyses.  
3.3 Overview of Latent Growth Curve Modelling 
Latent growth curve modelling (LGCM) is an analytic technique for longitudinal data 
that allows the assessment of trajectories of change, growth, or development of a 
particular outcome over time.
160
 This type of analysis is particularly well suited for panel 
data, where repeated observations are collected at approximately the same intervals.
160
 
Specifically, LGCM is able to accomplish three tasks important for the analysis of 
longitudinal data.  First, it can be used to model and describe change or development of a 
particular outcome at the group level by producing estimated means of parameters of an 
overall trajectory. In the case of a linear trajectory involving three or more observations, 
LGCM can produce model-estimated means of the intercept and slope of the overall 
trajectory. Second, LGCM can describe differences between individuals by producing 
estimates of the variance of intercept and slope parameters. Thus, a single analysis using 
LGCM can describe change or development of a particular outcome at the group level as 
well as the level of individual variance in developmental trajectories. Finally, LGCM can 
be used to assess the effects of predictors on the variance in trajectories in order to 
determine their impact on initial levels and rates of change of an outcome.  
The main purpose of the current study was to assess whether prenatal exposure to GDM 
can explain individual differences in early childhood BMI trajectories in order to 
ascertain the impact of prenatal exposure to GDM on the starting point and rate of 
increase in BMI throughout early childhood. Achieving this aim first required estimation 
of the means of BMI trajectory parameters for all children. The next step required 
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variances in BMI trajectory parameters to be estimated in order to determine whether 
significant differences exist between individual BMI trajectories. The final step was to 
assess whether prenatal exposure to GDM could partially explain the existing differences 
between individual trajectories in order to ascertain its potential role as a risk factor for 
high childhood BMI. The main characteristics of LGCM, as previously described, 
dovetail the aims of the current study, and thus it was the most appropriate analytic 
technique. For a detailed explanation of latent growth curve modelling please see 
Appendix B. All preliminary analyses were completed using IBM SPSS Statistics 
Software Version 21.
161
 Latent growth curve analyses were conducted using MPlus 
Version 7 Software.
162
  
3.4 Model Considerations 
3.4.1 Time Scores 
Although the NLSCY cycles occurred at two-year intervals, in reality, data were 
collected over a span of two years for each cycle. This raised the issue of unequal 
intervals at the individual level, thus intervals needed to be adjusted for time of data 
collection. In Mplus, this is done using time scores, which account for individually 
varying times of observation in panel data by using variables containing information 
about individual times of observation to model trajectories over time. The use of time 
scores in the current study ensures that estimates for the parameters of individual BMI 
trajectories are based on data that reflect the correct timing of change in BMI rather than 
assuming changes in BMI consistently occurred over two years between data collection 
points.  
3.4.2 Model Fit 
Establishing model fit, that is, assessing how well a given model reflects the data is an 
important preliminary step in latent growth curve analyses. Several goodness of fit 
indices are available in Mplus
162
 that take into account differences between observed and 
implied variance-covariance matrices as well as degrees of freedom and model 
complexity to produce a measure of model fit.
160
 Some of these indices include the chi-
square test statistic, the comparative fit index (CFI), the Tucker-Lewis index (TLI), and 
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the root mean square error of approximation (RMSEA).
160
 These model fit indices 
produce absolute measures of goodness of fit, for example, the closer the RMSEA value 
is to zero the better the model fit.
160
  Other model fit indices produce values that must be 
compared between models to assess improvements in model fit, such as the Bayesian 
information criterion (BIC), Akaike’s information criterion (AIC), and the 
loglikelihood.
160
   
In the current study, the chi-square test statistic and other chi-square related model fit 
statistics (CFI, TLI, RMSEA) were unavailable due to the use of time scores. This is 
because the use of time scores requires LGCMs to be modelled with random slopes, 
which results in insufficient statistics (means, variances, and covariances) for model 
estimation using these model fit assessment tools. Model fit was therefore assessed using 
BIC value comparisons and loglikelihood differences for all LGCMs. Model suggestions 
produced by program outputs were only taken into consideration if they were 
theoretically sound and reduced BIC values by a large degree.  
3.4.3 Missing Data 
In Mplus, the issue of missing data is addressed in different ways depending on the type 
of data that are missing.
162
 First, Mplus does not allow missing data for any exogenous 
variables, that is, for variables that are not predicted by other variables in the model and 
are thus considered external to the model.
162
  Cases that have missing values for any 
exogenous variables are automatically excluded from all analyses.
162
 This is because 
models are conditional on the exogenous variables and cannot be estimated overall if 
there are any missing values in these predictor variables.
162
 In the current study missing 
data of this nature are a concern as there are a number of predictor variables included in 
analyses, which could result in many excluded cases due to missing values in any of the 
predictors. Since Mplus allows for missing data in endogenous variables,
162
 that is, 
variables that are predicted by others in the model, this problem is attenuated by 
specifying causal relationships between predictors and thus converting exogenous 
predictors into endogenous predictors. A description and justification of the added causal 
relationships between predictors is provided in Section 3.5.3 below in the description of 
analyses for Objective 2.  
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In the current study, missing data on child BMI was inevitable due to attrition throughout 
cycles of the NLSCY. Missing data of this nature are considered to be “missing at 
random” (MAR) since the reason for missingness is not related to the missing values 
themselves.
163 164
 In this case, missing data on child BMI are likely not explained by 
specific BMI values. Instead, probabilities of missingness in the MAR scenario may be a 
product of other observed variables included in the models,
163 164
 for example household 
income, maternal education, or other predictor variables included in analyses. However, 
this type of missingness is considered “ignorable” and does not require further 
consideration or adjustment.
163 164
 In Mplus, full-information maximum likelihood 
(FIML) is used to adjust for MAR data.
162
 FIML does not impute missing values, rather it 
calculates the maximized likelihood of MAR data given a set of observed values in order 
to produce parameter estimates.
165
 For cases with incomplete data, FIML uses all data 
available for each case to produce casewise likelihood functions that are summed across 
the study sample and maximized.
165
  
3.4.4 Power and Precision 
The use of Monte Carlo simulations has been recommended for calculating power and 
minimal sample size for growth analyses and analyses using structural equation 
modelling (SEM).
166
  However, this technique requires specification of a conceptual 
model with population values for all parameters using “best estimates” from previous 
studies.
166
 This is not feasible for the current study since no previous studies have used a 
structural equation-based model for the effect of GDM exposure on childhood growth 
trajectories.  Thus, the current study followed general sample size guidelines suggested in 
the literature for sufficient statistical power to conduct SEM-based analyses such as 
LGCM.
166
 
167
 These guidelines suggest a minimum of 200 subjects per group,
168
 
167
 
which in the case of the current study would suggest a minimum of 200 females and 200 
males for analyses. Indeed, Hoyle
167
 suggests that a sample of 300 subjects used for SEM 
analyses typically results in stable model estimates. 
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3.5 Statistical Analyses 
3.5.1 Preliminary Analyses 
Preliminary analyses were done to determine the characteristics of the study population. 
For the main outcome of interest, BMI, means and standard deviations of BMI scores at 
each time point were calculated.  Descriptive statistics for all other key variables in the 
analyses were also produced. For the categorical variables, parity, smoking during 
pregnancy, highest level of maternal education, income adequacy, prenatal exposure to 
GDM, and breastfeeding, frequencies and percentages were calculated. For the 
continuous variables, maternal age, and birth weight for gestational age z-score, means 
and standard deviations were calculated. All descriptive statistics were produced 
separately by child gender and weighted using cross-sectional weights from the first cycle 
of data collection to reflect initial sampling design.  
The following is the trajectory equation that summarizes all latent growth curve analyses. 
                 
                     (1) 
where BMIit represents the BMI score for the ith individual at time t; λt is a constant fixed 
to the values 0, 1, 2, 3, and 4 for the linear component of the slope of the trajectory; and 
λt
2
 are simply these values squared for the quadratic component of slope. The symbol ϵit 
indicates the random error for each individual observed measure (i) at each time point (t).  
After establishing model fit, the first step was to ensure that variances in overall BMI 
trajectories were statistically significant to justify subsequent conditional analyses with 
explanatory variables. This was done using the unconditional LGCM.  This model 
included specified latent variables for the intercept, the linear component of slope, and 
the quadratic component of slope as well as the observed variables for BMI at ages 2, 4, 
6, 8, and 10 years (Figure 3.1).  The unconditional latent growth curve analyses were 
done separately for females and males. 
To account for differences in child age at the first cycle used in the study, a new age 
correction variable was calculated by centring age in years at Cycle 2 on 2, since this was 
the expected age of children at this initial cycle. The intercept, the linear component of 
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slope, and the quadratic component of slope were then regressed on this age correction 
variable. This was done in all subsequent latent growth curve analyses. For simplicity, the 
age correction variable will not be shown in regression equations for the intercept or the 
linear and quadratic components of slope in the sections that follow.  
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Figure 3.1. Unconditional latent growth curve model for preliminary analyses, showing 
each of the fixed factor loadings for intercept and linear and quadratic slope for the 
theorized quadratic model. 
3.5.2 Analyses for Objective 1 
The first objective was to assess the direct effect and indirect effect, through birth weight 
for gestational age, of prenatal exposure to GDM on childhood BMI trajectories from 2 to 
10 years of age. This was done by converting the unconditional LGCM to a conditional 
LGCM by adding the variables for prenatal exposure to GDM and birth weight for 
gestational age to the model (Figure 3.2). The conditional LGCM in Figure 3.2 is 
summarized by the regression equations 1.1 – 1.4 below. The direct effect of prenatal 
exposure to GDM was modelled by regressing the intercept, the linear component of 
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slope, and the quadratic component of slope on the variable for prenatal exposure to 
GDM (      . The indirect effect was modelled first by regressing the variable for birth 
weight for gestational age (     ) on the variable for prenatal exposure to GDM (1.4) and 
subsequently regressing the intercept, the linear component of slope, and the quadratic 
component of slope on the variable for birth weight for gestational age (1.1-1.3). The 
conditional latent growth curve analyses for Objective 1 were done separately for females 
and males. 
Latent trajectory parameters
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Figure 3.2. Conditional latent growth curve model for Objective 1. Direct and indirect 
effects of prenatal exposure to GDM on BMI trajectories. Note: Covariances are not 
shown. Latent variables are grouped in the diagram for simplicity.  
Intercept equation: 
                                    (1.1) 
Slope equation (linear component): 
                                       (1.2) 
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Slope equation (quadratic component): 
                                          (1.3) 
*Birth weight for gestational age equation: 
                                (1.4) 
The use of time scores, explained in Section 3.4.1, to model BMI trajectories did not 
permit Mplus software to test indirect effects using the MODEL INDIRECT command. 
Therefore, the indirect effect of prenatal exposure to GDM on BMI trajectories through 
birth weight for gestational age was calculated manually using the Sobel test for indirect 
effects.
169-171
 Figure 3.3 is presented to conceptualize the Sobel test, in which the model 
with the mediator to be tested is pictured. The letters a and b represent the estimates of 
each pathway of the indirect effect, while the letter c represents the estimate of the 
pathway for the direct effect (Figure 3.3). The calculation of the test statistic for the Sobel 
test of indirect effects is presented in the equation below: 
                
                (2) 
where the denominator is the pooled standard error, in which     is the variance of the 
estimate b and     is the variance of the estimate a. This test statistic was calculated 
separately for each trajectory parameter to test the indirect effect on BMI trajectories. 
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Figure 3.3. Parameters of the Sobel test for indirect effects.  
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3.5.3 Analyses for Objective 2 
The second objective was to assess whether the effect of prenatal exposure to GDM could 
be partially explained by maternal demographic, lifestyle, and socioeconomic factors that 
are associated with GDM and that also predict birth weight for gestational age and 
childhood BMI trajectories. These potential confounders were maternal age, parity, 
smoking during pregnancy, maternal highest level of education, and income adequacy for 
the household, which were included in a new conditional LGCM (Figure 3.4).  
The conditional LGCM in Figure 3.4 is summarized by the regression equations 1.5 – 
1.14 below. This conditional LGCM differs from the conditional LGCM for Objective 1 
in several ways. First, the intercept, the linear component of slope, and the quadratic 
component of slope are now also regressed on the variables for maternal age (         ), 
parity (        ), smoking during pregnancy (       ), maternal highest level of 
education (           ), and income adequacy for the household (        ) (1.5 – 1.7). 
Birth weight for gestational age is also regressed on these variables in the new 
conditional LGCM (1.8). The variable for prenatal exposure to GDM becomes an 
endogenous variable in this conditional LGCM as it is regressed on maternal age, parity, 
smoking during pregnancy, maternal highest level of education, and income adequacy for 
the household (1.9).  
The variables for parity, smoking during pregnancy, maternal highest level of education, 
and income adequacy for the household were regressed on maternal age (1.10 – 1.14). 
These variables were modelled in this way to reduce the number of missing cases due to 
missing values on exogenous variables, as maternal age was the variable containing the 
fewest missing values. Maternal age is also a theoretically sound predictor of parity, 
smoking during pregnancy, maternal highest level of education, and income adequacy for 
the household. Other relationships between the predictor variables were not of 
substantive interest to the hypotheses under examination. However, the variables for 
parity, smoking during pregnancy, maternal highest level of education, and income 
adequacy for the household were correlated in the model. The conditional latent growth 
curve analyses for Objective 2 were done separately for females and males.  
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Figure 3.4. Conditional latent growth curve model for Objective 2. Direct and indirect effects of prenatal exposure to GDM on BMI 
trajectories adjusted for maternal age, parity, smoking during pregnancy, maternal highest level of education, and income adequacy 
for the household. Note: Covariances are not shown. Latent variables are grouped in the diagram for simplicity.   
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Intercept equation: 
                                                              
                                
Slope equation (linear component): 
                                         
               
                                             
Slope equation (quadratic component): 
                                         
               
                                             
*Birth weight for gestational age equation: 
                                                                    
                                         
Additional equations:  
                         
                                
                                        
                         
                                
                                          (1.10) 
                               
                              
                                  
                               
(1.5) 
(1.6) 
(1.7) 
(1.8) 
(1.9) 
(1.11) 
(1.12) 
(1.13) 
(1.14) 
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3.5.4 Analyses for Objective 3 
The third objective was to assess whether breastfeeding initiation modified the direct and 
indirect effects of prenatal exposure to GDM on childhood BMI trajectories. This was 
done by repeating the analyses done for Objective 2 separately by breastfeeding, that is, 
whether the child was breastfed or was not breastfed.  These analyses were thus 
conducted for 4 different groups: females who were not breastfed, females who were 
breastfed, males who were not breastfed, and males who were breastfed.  To examine 
differences by breastfeeding initiation/non-initiation within each sex-specified group, 
95% confidence intervals were produced for the following parameters: the estimated 
means and variances for the intercept, linear component of slope, and quadratic 
component of slope for BMI trajectories; the estimated coefficients for the effect of 
prenatal exposure to GDM on the intercept, linear component of slope and quadratic 
component of slope for BMI trajectories; and the estimated coefficient for the effect of 
prenatal exposure to GDM on birth weight for gestational age.  To compare overall 
differences in BMI trajectories between children who were breastfed and children who 
were not breastfed, 95% confidence intervals for the estimated means and variances for 
the intercept, linear component of slope, and quadratic component of slope were 
compared between breastfeeding groups. To examine modification of the effect of 
prenatal exposure to GDM on BMI trajectories by breastfeeding, 95% confidence 
intervals model-estimated coefficients for the effect of prenatal exposure to GDM on the 
intercept, linear component of slope, and quadratic component of slope were compared 
between breastfeeding groups.  
Conventional methods for testing differences between groups in Mplus, such as multi-
group analyses, were unavailable for the model used. This was due to the use of time 
scores, a technique that allows individual variation in observation times for panel data, 
which results in different variance/covariance matrices for each individual. As a result, 
Mplus software is unable to conduct multi-group analysis for models employing the use 
of time scores.  
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4 Results 
This chapter begins with an overview of the study population characteristics, including 
characteristics at baseline as well as throughout NLSCY cycles (Section 4.1). The 
remaining sections outline results of each of the latent growth curve models (LGCMs), 
beginning with the unconditional LGCM (Section 4.2), followed by the unadjusted 
conditional LGCM examining the direct and indirect effects of prenatal exposure to 
GDM on childhood BMI trajectories (Section 4.3.1), the conditional LGCM adjusted for 
important confounding variables (Section 4.3.2), and finally the stratified conditional 
LGCMs examining effect modification by breastfeeding (Section 4.3.3). For all statistical 
tests, a significance level of α = 0.05 is used.  
4.1 Characteristics of the Study Population  
The initial study population, which was defined as all children aged 0-1 year in cycle 1 
(1994-1995) who contributed longitudinal data, consisted of 3,619 children. After 
exclusion of 207 twins, the final study sample included 3,412 children. Further 
exclusions were made automatically during latent growth curve analyses, and were due to 
missing values in any exogenous   variables (i.e. missing values for exogenous 
predictors, in this case, maternal age) or missing values for all observed   variables (i.e. 
missing BMI trajectories). These excluded cases are further described in the sections 
below in the results of latent growth curve analyses.  
Of the 3,412 children in the study sample, 1651 (48.4%) are female and 1761 (51.6%) are 
male. Nearly twice as many male than female children were exposed to GDM prenatally 
in the study population, with 127 (7%) mothers of male children and 73 (4%) mothers of 
female children reporting GDM diagnosis during pregnancy. As all analyses are 
conducted separately by gender, study sample characteristics at baseline are also 
presented separately for females and males (Table 4.1). Mean age and mean BMI score at 
each cycle are presented in Table 4.2. Mean BMI score at each cycle by GDM exposure 
group is presented in Table 4.3. 
Almost 20% of children (306 females and 328 males) were born into households with 
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less than average income adequacy, that is, households in the lowest and lower-middle 
income adequacy categories. Around 30% of children (497 females and 514 males) were 
born into households that fell in the middle category for income adequacy. Of the 
remaining 51% of children, approximately 38% (640 females and 676 males) were born 
to households classified as upper-middle income adequacy and almost 13% (208 females 
and 223 males) were born into households with the highest level of income adequacy.  
For the vast majority (91-92%) of children included in the study, the PMK for the child 
was the biological mother. Average maternal age at the index pregnancy was 
approximately 30 ± 5 years for both females and males. For approximately 37% of 
mothers, the child included in the survey was their first child. Around 16% of mothers of 
both female and male children in the study sample were less than secondary school 
educated at the time of birth of the child included in the survey; 271 and 295 mothers of 
female and male children, respectively, did not complete secondary school graduation.  
Approximately 16% of mothers (257 mothers of female and 294 mothers of male 
children) in the study had completed secondary school graduation, while the remaining 
two-thirds of mothers completed some form of education beyond secondary school at the 
time of birth of the child included in the survey. Approximately 20% of mothers (338 
mothers of female and 367 mothers of male children) reported ever smoking during 
pregnancy with the child. Finally, 23% (397) of mothers of female children and 24% 
(408) of mothers of male children reported never having breastfed their child while the 
remaining 75% in each group reported having breastfed their child at least for a short 
while.   
4.2 Unconditional Latent Growth Curve Analysis 
Quadratic unconditional LGCMs for females (N=1611) and males (N=1691) were 
estimated using maximum likelihood estimation with robust standard errors to model 
BMI from age 2 to 10 years. Excluded cases were those that had missing data for all 
variables except  -variables, that is, cases with missing BMI trajectories (females: N=57, 
males: N=52). Model results for unconditional latent growth curve analyses are 
summarized in Table 4.4*. Model fit for the unconditional quadratic was assessed using 
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the BIC values (BIC, females = 30420.626; BIC, males = 29787.174), which were lower 
in the quadratic unconditional LGCM than in the linear unconditional LGCM (data not 
shown).  Significant inter-individual variability in childhood BMI trajectories was found 
for both females and males in terms of the intercept (females:        , S.E.      , 
       ; males:        , S.E.      ,        ), linear component of slope 
(females:         S.E.      ,        ; males:        , S.E.      , 
       ), and quadratic component of slope (females:         S.E.      , 
      ; males:        , S.E.      ,        ).  Significant covariance was 
found between the intercept and the linear component of slope (  ) for both males and 
females. Intercepts covaried significantly with the quadratic component of slope (  ) 
only for males. The average BMI trajectory for females in the study sample starts at a 
BMI score of 17.9 at 2 years of age, with adiposity rebound appearing to occur before the 
age of 6 years (Figure 4.1). The average BMI trajectory for males in the study sample has 
a similar starting point, with adiposity rebound occurring at around 6 years of age (Figure 
4.1).  
4.3 Conditional Latent Growth Curve Analyses 
4.3.1 Unadjusted Direct and Indirect Pathways 
Results of the conditional LGCM for the direct effect of prenatal exposure to GDM and 
the indirect effect through birth weight for gestational age for females (N=1555) and 
males (N=1619) are shown in Table 4.5 and Figure 4.2. The cases excluded from 
analyses were those that had missing data on predictor variables and missing BMI 
trajectories (females: N=113, males: N=124). For both females and males, BIC values 
increased from the unconditional model (BIC, females = 30420.626; BIC, males = 
29787.174) to the conditional model (BIC, females = 32779.035; BIC, males = 
32409.456).  
From the unconditional model to the conditional model, variance in the intercept ( ) of 
BMI trajectories for females was reduced by 12% (unconditional:   
      , S.E. 
     ,        ; conditional:   
      , S.E.      ,        ), while variances 
in the linear (  ) and quadratic (  ) components of slope remained the same.  For males, 
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variance of the intercept was reduced by 7% from the unconditional model to the 
conditional model (unconditional:   
      , S.E.      ,        ; conditional: 
  
      , S.E.      ,        ), while variances of the linear and quadratic 
components of slope remained approximately the same (Table 4.5).    
In this model prenatal exposure to GDM (     ) only has a significant effect on the 
intercept of BMI trajectories for males, reducing the model estimated BMI score at age 2 
by nearly 1 point (estimated effect on intercept       , S.E.      ,       ). The 
effects of prenatal exposure to GDM on the linear and quadratic components of slope for 
both males and females and on the intercept for females did not reach statistical 
significance (Table 4.5).   
The Sobel test for significance of a mediation effect did not reveal a statistically 
significant indirect effect (through birth weight for gestational age) of prenatal exposure 
to GDM on any BMI trajectory parameters for females or males (Table 4.6).  The p-
values for the tests of the indirect effect of prenatal exposure to GDM on the intercept, 
linear slope, and quadratic slope for females ranged from 0.25 to 0.34. The p-values for 
the tests of the indirect effect of prenatal exposure to GDM on the intercept, linear slope, 
and quadratic slope for males ranged from 0.67 to 0.70. 
4.3.2 Adjusted Effects of Prenatal Exposure to GDM on Childhood 
BMI Trajectories  
Model results for the conditional LGCM of the direct effect of prenatal exposure to GDM 
and the indirect effect through birth weight for gestational age, adjusted for maternal age, 
parity, maternal highest level of education, household income adequacy, and smoking 
during pregnancy are shown in Table 4.7. Model results for all other covariates are 
provided in Appendix C. Automatically excluded cases were those for which data on 
exogenous variables were missing (females: N=114, males: N=128). For both females 
and males, BIC values increased from the unadjusted conditional model (BIC, females = 
32779.035; BIC, males = 32409.456) to the adjusted conditional model (BIC, females = 
47769.572; BIC, males = 48603.247).  
Variance of the intercept of BMI trajectories for females was reduced by 9% from the 
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unadjusted to the adjusted conditional LGCM (unadjusted:   
      , S.E.      , 
       ; adjusted:   
      , S.E.      ,        ). Also for females, variance 
of the linear component of slope decreased by 5% from the unadjusted to the adjusted 
conditional LGCM (unadjusted:    
       , S.E.      ,       ; adjusted: 
   
       , S.E.      ,       ). The quadratic component of slope (  ) remained 
the same for females.  For males, variance of the intercept of BMI trajectories decreased 
by 7% from the unadjusted to the adjusted conditional LGCM (unadjusted:   
      , 
S.E.      ,        ; adjusted:   
      , S.E.      ,        ). Variance of 
the linear component of slope was reduced by 6% from the unadjusted to the adjusted 
conditional LGCM (unadjusted:    
       , S.E.      ,        ; adjusted: 
   
       , S.E.      ,        ). Variance of the quadratic component of slope 
also remained approximately the same for males (Table 4.6).   
The effect of prenatal exposure to GDM (     ) on the intercept of BMI trajectories for 
males in the study sample remains significant in the adjusted model. The effect of 
prenatal exposure to GDM on the linear and quadratic components of the slope of BMI 
trajectories did not reach statistical significance for males or females. There was also no 
statistically significant effect of prenatal exposure to GDM on the intercept of BMI 
trajectories for females (Table 4.7).  Adjusted childhood BMI trajectories for females and 
males with and without prenatal exposure to GDM are shown in Figure 4.2.  
4.3.3 Modification by Breastfeeding 
Effect modification of the association between prenatal exposure to GDM and childhood 
BMI trajectories by breastfeeding was examined using stratified conditional latent growth 
curve analyses adjusted for maternal age, parity, maternal highest level of education, 
household income adequacy, and smoking during pregnancy. Analyses were stratified by 
gender and breastfeeding history, resulting in four groups; females who were never 
breastfed, females who were breastfed, males who were never breastfed, and males who 
were breastfed. Model results for the adjusted conditional LGCM for each of the four 
groups are presented in Table 4.8 and Table 4.9. Additional model results are provided in 
Appendix C. The number of cases excluded in analyses due to missing data on exogenous 
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variables was 113 for females and 125 for males. BIC values decreased substantially with 
stratified models versus all previous models for both females (Never breastfed: BIC = 
11625.542; Breastfed: BIC = 35576.190; Table 4.8) and males (Never breastfed: BIC = 
13350.902; Breastfed: BIC = 34740.127; Table 4.9).  
Residual variances of trajectory parameters changed from the overall adjusted LGCMs to 
the adjusted LGCMs stratified by breastfeeding initiation/non-initiation. The exception 
for all models was residual variances of the quadratic components of slope, which 
remained relatively unchanged from overall adjusted to stratified adjusted models. 
Variances of all trajectory parameters remained statistically significant in all models 
stratified by breastfeeding initiation/non-initiation except among never breastfed females. 
For females, residual variance of the intercept of BMI trajectories decreased by almost 
32% from the overall adjusted LGCM to the adjusted LGCM for never breastfed females 
(overall females:   
      , S.E.      ,        ; never breastfed females: 
  
      , S.E.      ,       ). Residual variance for the linear component of 
slope decreased by 30% from the overall LGCM for females to the LGCM for never 
breastfed females (overall females:    
       , S.E.      ,       ; never 
breastfed females:    
       , S.E.      ,       ). In the adjusted LGCM for 
breastfed females, residual variance of the intercept of BMI trajectories increased by 10% 
from the overall adjusted LGCM (overall females:   
      , S.E.      ,        ; 
breastfed females:   
      , S.E.      ,        ). Residual variance of the linear 
component of slope also increased for breastfed females by 15% from the overall LGCM 
for females to the LGCM for breastfed females (overall females:    
       , S.E. 
     ,        ; breastfed females:    
       , S.E.      ,       ).  
In the adjusted LGCM for never breastfed males, residual variance of the intercept of 
BMI trajectories decreased by almost 12% from the overall adjusted LGCM (overall 
males:   
      , S.E.      ,        ; never breastfed males:   
      , 
S.E.      ,       ). Residual variances for the linear component of slope increased 
by almost 49% from the overall LGCM for males to the LGCM for never breastfed males 
(overall males:    
       , S.E.      ,        ; never breastfed males:    
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     , S.E.      ,       ). In the adjusted LGCM for breastfed males, residual 
variance of the intercept of BMI trajectories decreased by 8% from the overall adjusted 
LGCM (overall males:   
      , S.E.      ,        ; breastfed males:   
  
    , S.E.      ,        ). Residual variances for the linear component of slope 
also decreased for breastfed males by almost 24% from the overall LGCM for males to 
the LGCM for breastfed males (overall males:    
       , S.E.      ,        ; 
never breastfed males:    
       , S.E.      ,        ). 
BMI trajectories for children exposed and unexposed to GDM prenatally in each of the 
four groups are shown in Figure 4.3. Prenatal exposure to GDM (     ) only had a 
statistically significant effect on the intercept ( ) of BMI trajectories for males who were 
never breastfed (Table 4.9). The effect of prenatal exposure to GDM on other parameters 
of BMI trajectories for the three other groups did not reach statistical significance (Table 
4.8 and Table 4.9). Differences in the effect of prenatal exposure to GDM on BMI 
trajectories between children who were and were not breastfed were examined using 95% 
confidence intervals for model estimates of the effect of prenatal exposure to GDM on 
trajectory parameters (Table 4.10). Confidence intervals for each parameter estimate 
overlapped between breastfeeding groups, indicating no statistically significant 
modification of the effect of prenatal exposure to GDM on BMI trajectories by 
breastfeeding history. 
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Table 4.1. Baseline characteristics of study the population. 
Characteristic Females (N= 1651) Males (N=1761) 
   N  Value  N  Value  
Maternal              
Age at pregnancy – Yr (S.D.)  1517 30.6 (5.0) 1611 30.4 (5.0) 
Parity - %  
            Primiparous  608 36.8 658 37.4 
        Multiparous  920 55.7 932 52.9 
Highest level of education obtained - % 
            Elementary school 38 2.3 62 3.5 
        Some secondary school 233 14.1 233 13.2 
        Secondary school graduation 257 15.6 294 16.7 
        Other beyond high school 12 0.7 5 0.3 
        Some trade school 121 7.3 157 8.9 
        Some community college 273 16.5 207 11.8 
        Some university 93 5.6 85 4.8 
        Diploma/certificate trade school 147 8.9 194 11.0 
        Diploma/certificate community college 184 11.1 185 10.5 
        Bachelor degree 248 15.0 263 14.9 
        Masters, degree in medicine, doctorate 40 2.4 72 4.1 
Household 
    Income adequacy for household size - % 
            Lowest 67 4.1 73 4.1 
        Lower middle 239 14.5 275 15.6 
        Middle 497 29.7 514 29.2 
        Upper middle 640 38.8 676 38.4 
        Highest 208 12.6 223 12.7 
Pregnancy  
    GDM diagnosis - %  
            Yes  73 4.4 127 7.2 
        No  1441 87.3 1489 84.6 
Smoked during pregnancy - %  
            Yes  338 20.5 367 20.8 
        No  1177 72.3 1249 75.7 
At birth  
    Weight – kg (S.D.)  1636 3.36 (0.55) 1748 3.52 (0.56) 
Length – m (S.D.)  1496 0.51 (0.04) 1631 0.52 (0.04) 
Gestational age – wk (S.D.)  1638 39.1 (1.68) 1758 39.2 (1.73) 
Birth weight for gestational age z-score 1636 0.19 (1.10) 1748 0.26 (1.03) 
During infancy              
Breast fed - %  
   
   
        Yes  1238  75.0  1321  75.0  
        No  397  24.0  408  23.2   
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Table 4.2. Mean age in months and BMI score for each cycle. 
Characteristic Females  Males  
   N  Value  N  Value  
Age – months (S.D.)  
   
   
        Cycle 2  1651  35.7 (6.5)  1761  35.8 (6.5)   
        Cycle 3  1538  58.3 (6.6)  1615  58.3 (6.7)   
        Cycle 4  1400  84.7 (6.9)  1463 84.5 (7.2)   
        Cycle 5  1359  105.2 (6.6)  1412  105.3 (6.8)   
        Cycle 6 1249  133.3 (6.6)  1285 133.2 (6.7)   
     BMI – score (S.D.)  
   
   
        Cycle 2  1351  17.5 (2.77)  1408  17.6 (2.45)   
        Cycle 3  1267  16.8 (2.82)  1240  16.9 (2.50)   
        Cycle 4  1156  17.0 (3.34)  1142  16.9 (2.96)   
        Cycle 5  1152  17.6 (3.61)  1195  17.9 (3.64)   
        Cycle 6 1067  18.6 (3.46)  1077  19.2 (3.99)   
 
Table 4.3. Mean BMI score at each cycle by exposure group. 
Exposure Group Females  Males  
   N  BMI Score N  BMI Score 
GDM – “No”  
   
   
        Cycle 2  1210 17.6 1243  17.7 
        Cycle 3  1130 16.9 1083 16.9 
        Cycle 4  1028 17.0 1003 16.9 
        Cycle 5  1032 17.7 1032 17.8 
        Cycle 6 945 18.7 917 19.1 
     GDM – “Yes”  
   
   
        Cycle 2  65 16.5 96 16.8 
        Cycle 3  64 16.1 101 16.0 
        Cycle 4  63 16.3 89 16.8 
        Cycle 5  44 17.4 93 18.3 
        Cycle 6 48 18.5 86 19.8 
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Figure 4.1. Unconditional latent growth curve model of childhood BMI trajectories from 
age 2 to 10 years.  
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Table 4.4. Results of Unconditional LGCM by gender. 
 
Females (N= 1611) Males (N=1691) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Intercepts  
  
 
  
 
        (intercept) 17.91 (0.176) 101.81 0.000 17.97 (0.138) 129.95 0.000 
         (linear slope) -0.57 (0.103) -5.51 0.000 -0.61 (0.085) -7.14 0.000 
         (quadratic slope)  0.08 (0.013) 6.47 0.000 0.09 (0.010) 8.819 0.000 
   
 
  
 
Covariances 
  
 
  
 
        with    -0.99 (0.478) -2.07 0.039 -0.86 (0.348) -2.46 0.014 
        with    0.07 (0.049) 1.40 0.161 0.08 (0.037) 2.09 0.037 
         with    -0.08 (0.033) -2.48 0.013 -0.10 (0.020) -4.75 0.000 
   
 
  
 
Residual Variances 
  
 
  
 
        (intercept) 4.74 (0.932) 5.08 0.000 3.45 (0.681) 5.07 0.000 
         (linear slope) 0.85 (0.296) 2.88 0.004 0.87 (0.181) 4.80 0.000 
         (quadratic slope)  0.01 (0.004) 2.40 0.016 0.01 (0.003) 5.13 0.000 
      BMI at 2 Yr  2.85 (0.842) 3.38 0.001 2.46 (0.674) 3.65 0.000 
      BMI at 4 Yr 4.69 (0.472) 9.93 0.000 3.90 (0.321) 12.17 0.000 
      BMI at 6 Yr 6.17 (0.963) 6.41 0.000 4.41 (0.512) 8.61 0.000 
      BMI at 8 Yr 7.85 (0.747) 4.49 0.000 7.01 (1.187) 5.90 0.000 
      BMI at 10 Yr 4.57 (1.791) 2.55 0.011 3.90 (1.635) 2.39 0.017 
       
Model Fit Measures 
   
 
      Loglikelihood (Null Value) -15147.544 -14830.406 
      BIC 30420.626 29787.174 
      Sample-size adjusted BIC 30366.620 29733.167 
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Table 4.5. Conditional LGCM for the direct effect of prenatal exposure to GDM and indirect effect through birth weight for 
gestational age. Model results by gender. 
 
Females (N= 1555) Males (N=1619) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Regression Weights 
  
 
  
 
        (intercept) ON        -0.855 (0.536) -1.594 0.111 -0.929 (0.354) -2.627 0.009 
        (intercept) ON        0.208 (0.106) 1.966 0.049 0.234 (0.089) 2.620 0.009 
         (linear slope) ON       0.042 (0.222) 0.188 0.851 0.199 (0.259) 0.769 0.442 
         (linear slope) ON       -0.075 (0.058) -1.289 0.197 -0.063 (0.060) -1.041 0.298 
         (quadratic slope) ON       0.005 (0.028) 0.195 0.845 0.000 (0.035) 0.005 0.996 
         (quadratic slope) ON       0.011 (0.007) 1.493 0.135 0.007 (0.008) 0.861 0.389 
            ON       0.294 (0.205) 1.437 0.151 0.082 (0.188) 0.433 0.665 
   
 
  
 
Residual Variances 
  
 
  
 
        (intercept) 4.181 (0.892) 4.689 0.000 3.216 (0.687) 4.683 0.000 
         (linear slope) 0.848 (0.314) 2.704 0.007 0.857 (0.184) 4.654 0.000 
         (quadratic slope)  0.011 (0.004) 2.450 0.014 0.013 (0.003) 5.055 0.000 
   
 
  
 
Model Fit Measures 
   
 
      Loglikelihood (Null Value) -16293.977 -16108.664 
      BIC 32779.035 32409.456 
      Sample-size adjusted BIC 32696.439 32326.859 
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Table 4.6. Results of the Sobel test for the indirect effect through birth weight for 
gestational age of prenatal exposure to GDM on childhood BMI trajectory parameters. 
Trajectory Parameter Females Males 
Intercept 
  
    Sobel test statistic 1.158 0.430 
    p-value 0.247 0.667 
Slope (Linear) 
  
    Sobel test statistic -0.960 -0.403 
    p-value 0.337 0.687 
Slope (Quadratic)   
    Sobel test statistic 1.059 0.390 
    p-value 0.289 0.696 
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Table 4.7. Conditional LGCM for the direct effect of prenatal exposure to GDM and indirect effect through birth weight for 
gestational age, adjusted for maternal age, parity, smoking during pregnancy, household income adequacy, and maternal highest level 
of education. Model results by gender 
 
Females (N= 1555) Males (N=1619) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Regression Weights 
  
 
  
 
      (intercept) ON        -0.901 (0.471) -1.914 0.056 -0.933 (0.381) -2.449 0.014 
      (intercept) ON        0.213 (0.105) 2.025 0.043 0.259 (0.100) 2.573 0.010 
       (linear slope) ON       0.060 (0.218) 0.274 0.784 0.144 (0.258) 0.558 0.577 
       (linear slope) ON       -0.082 (0.060) -1.381 0.167 -0.045 (0.059) -0.769 0.442 
       (quadratic slope) ON       -0.002 (0.028) -0.074 0.941 -0.008 (0.033) -0.238 0.812 
       (quadratic slope) ON       0.013 (0.008) 1.767 0.077 0.007 (0.007) 0.883 0.377 
          ON       0.357 (0.162) 2.200 0.028 0.165 (0.164) 1.003 0.316 
       
  
 
  
 
Residual Variances 
  
 
  
 
        (intercept) 3.789 (0.875) 4.332 0.000 2.988 (0.653) 4.576 0.000 
         (linear slope) 0.808 (0.303) 2.667 0.008 0.805 (0.179) 4.491 0.000 
         (quadratic slope)  0.011 (0.004) 2.455 0.014 0.012 (0.003) 4.570 0.000 
   
 
  
 
Model Fit Measures 
   
 
      Loglikelihood (Null Value) -23623.888 -24039.382 
      BIC 47769.572 48603.247 
      Sample-size adjusted BIC 47544.022 48377.693 
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Figure 4.2. Results of analyses for Objectives 1 and 2. Unadjusted and adjusted latent growth curve models (LGCMs) of early 
childhood BMI trajectories for children with and without prenatal exposure to GDM. Model results by gender. Note: adjusted LGCMs 
are controlled for maternal age, parity, smoking during pregnancy, household income adequacy, and maternal education. 
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Table 4.8. Results of Objective 3 conditional LGCM by breastfeeding for females.  
 
Never Breastfed (N= 390) Breastfed (N=1152) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Regression Weights 
  
 
  
 
      (intercept) ON        -0.627 (0.726) -0.864 0.388 -1.042 (0.586) -1.777 0.075 
      (intercept) ON        0.219 (0.222) 0.984 0.325 0.217 (0.117) 1.846 0.065 
       (linear slope) ON       0.171 (0.315) 0.542 0.588 0.154 (0.291) 0.528 0.597 
       (linear slope) ON       -0.130 (0.104) -1.249 0.212 -0.085 (0.070) -1.207 0.228 
       (quadratic slope) ON       -0.008 (0.041) -0.198 0.843 -0.016 (0.034) -0.482 0.630 
       (quadratic slope) ON       0.019 (0.012) 1.591 0.112 0.014 (0.009) 1.573 0.116 
          ON       0.589 (0.249) 2.364 0.018 0.317 (0.207) 1.527 0.127 
       
  
 
  
 
Residual Variances 
  
 
  
 
        (intercept) 2.592 (1.478) 1.754 0.079 4.181 (1.056) 3.959 0.000 
         (linear slope) 0.563 (0.414) 1.361 0.174 0.927 (0.374) 2.480 0.013 
         (quadratic slope)  0.010 (0.006) 1.636 0.102 0.012 (0.005) 2.150 0.032 
   
 
  
 
Model Fit Measures 
   
 
      Loglikelihood (Null Value) -5600.973 -17717.095 
      BIC 11625.542 35934.687 
      Sample-size adjusted BIC 11400.263 35709.169 
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Table 4.9. Results of Objective 3 conditional LGCM by breastfeeding for males. 
 
Never Breastfed (N= 428) Breastfed (N=1169) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Regression Weights 
  
 
  
 
      (intercept) ON        -1.529 (0.534) -2.864 0.004 -0.510 (0.382) -1.333 0.183 
      (intercept) ON        0.199 (0.184) 1.077 0.281 0.247 (0.115) 2.154 0.031 
       (linear slope) ON       0.259 (0.338) 0.768 0.443 -0.080 (0.232) -0.345 0.730 
       (linear slope) ON       -0.229 (0.127) -1.797 0.072 0.027 (0.062) 0.439 0.660 
       (quadratic slope) ON       -0.010 (0.044) -0.238 0.812 0.009 (0.027) 0.330 0.741 
       (quadratic slope) ON       0.042 (0.017) 2.529 0.011 -0.006 (0.008) -0.798 0.425 
          ON       -0.125 (0.249) -0.503 0.615 0.416 (0.151) 2.765 0.006 
       
  
 
  
 
Residual Variances 
  
 
  
 
        (intercept) 2.637 (1.210) 2.180 0.029 2.741 (0.716) 3.826 0.000 
         (linear slope) 1.197 (0.438) 2.732 0.006 0.615 (0.181) 3.408 0.001 
         (quadratic slope)  0.020 (0.007) 2.823 0.005 0.009 (0.003) 3.541 0.000 
   
 
  
 
Model Fit Measures 
   
 
      Loglikelihood (Null Value) -6460.352 -17119.295 
      BIC 13350.902 34740.127 
      Sample-size adjusted BIC 13125.591 34514.607 
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Table 4.10. Confidence intervals of Objective 3 LGCM estimates for comparison between breastfeeding groups.  
 
Females - Est. (95% CI) Males - Est. (95% CI) 
   Never Breastfed Breastfed Never Breastfed Breastfed 
Intercepts  
    
        (intercept) 
18.438  
(17.910,18.966) 
17.699  
(17.326,18.072) 
18.356  
(17.867,18.846) 
17.910  
(17.564,18.256) 
         (linear slope) -0.528 (-0.842,-0.214) -0.561 (-0.810,-0.311) -0.712 (-1.076,-0.348) -0.600 (-0.795,-0.406) 
         (quadratic slope)  0.080 (0.043,0.118) 0.082 (0.050,0.115) 0.106 (0.057,0.155) 0.093 (0.071,0.115) 
     
Residual Variances 
    
        (intercept) 2.592 (-0.305,5.489) 4.181 (2.111,6.251) 2.637 (0.266,5.007) 2.741 (1.337,4.146) 
         (linear slope) 0.563 (-0.248,1.375) 0.927 (0.194,1.659) 1.197 (0.338,2.056) 0.615 (0.261,0.969) 
         (quadratic slope)  0.010 (-0.002,0.022) 0.012 (0.001,0.022) 0.020 (0.006,0.033) 0.009 (0.004,0.014) 
     
Regression Weights 
    
       (intercept) ON        -0.627 (-2.049,0.795) -1.042 (-2.191,0.107) -1.529 (-2.575,- 0.482) -0.510 (-1.259,0.240) 
        (linear slope) ON       0.171 (-0.447,0.789) 0.154 (-0.417,0.724) 0.259 (-0.402,0.921) -0.080 (-0.535,0.375) 
        (quadratic slope) ON       -0.008 (-0.089,0.072) -0.016 (-0.083,0.050) -0.010 (-0.096,0.075) 0.009 (-0.043,0.061) 
           ON       0.589 (0.100,1.077) 0.317 (-0.090,0.723) -0.125 (-0.613,0.363) 0.416 (0.121,0.711) 
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Figure 4.3. Results of analyses for Objective 3. Latent growth curve models (LGCMs) of early childhood BMI trajectories for 
children with and without prenatal exposure to GDM stratified by breastfeeding history. Model results by gender. Note: LGCMs are 
controlled for maternal age, parity, smoking during pregnancy, household income adequacy, and maternal education. 
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5 Discussion 
This chapter presents discussions of the findings of the current study. Section 5.1 outlines 
the main research findings, discussing the significance of study results in context of the 
research objectives and the overall body of literature examining the association between 
maternal IGT during pregnancy and childhood overweight and obesity. This is followed 
by Section 5.2, which presents a discussion of the possible reasons for the statistically 
non-significant findings in the study. Section 5.3 discusses the limitations of this study 
and Section 5.4 discusses the study strengths. Finally, Section 5.5 provides a summary of 
the conclusions of the study and recommendations for further research. 
This study’s aim was to examine the association between GDM and early childhood BMI 
trajectories. The main prediction was that prenatal exposure to GDM is associated with 
BMI trajectories that exhibit unhealthy changes in child weight for height and the 
potential for overweight and obesity risk. Specific objectives of the study were to model 
early childhood BMI trajectories and examine the direct and indirect effects of prenatal 
exposure to GDM, adjusting for important confounding factors, as well as to explore 
breastfeeding as a potential effect modifier and protective factor.  
5.1 Overview of Research Findings 
5.1.1 Early Childhood BMI Trajectories  
As expected, BMI data for both female and male children in the study population fit a 
quadratic model of growth from the ages of 2 to 10 years. Childhood BMI trajectories 
exhibited an initial decline from the age of 2 years before steadily inclining through the 
age of 10 years for both females and males.  The timing of adiposity rebound, that is the 
point of renewed incline in BMI, occurred earlier on average in females compared to 
males in the study sample (Figure 4.1). Overall, according to the model, adiposity 
rebound appeared to occur between the ages of 5 and 6 years for females and males in the 
sample. This is consistent with the literature on timing of adiposity rebound, which states 
that minimum BMI during childhood occurs at 5 to 6 years of age.
65
  Also according to 
the modelled trajectories, females on average had higher BMI between the ages of 6 and 
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10 years than males in the study population (Figure 4.1).  
5.1.2 Inter-Individual Variability 
An important post hoc consideration is how much inter-individual variation was seen in 
trajectories. The amount of residual variance in trajectory parameters comparing one 
model to the next reveals important information about how representative an average 
trajectory is for the population being described. Indeed, the main advantage of latent 
growth curve analyses is the ability to simultaneously consider individual- and group-
level patterns in longitudinal data. 
At the outset, the study population showed significant variance in all BMI trajectory 
parameters (intercept, linear slope, and quadratic slope), which provided justification for 
further analyses. The addition of prenatal exposure to GDM as a predictor of BMI 
trajectories explained 12% and 7% of the variance in the intercepts of BMI trajectories 
for females and males, respectively, and explained none of the variance in slopes. 
Significant residual variance in all trajectory parameters remained in this model. As this 
first model was unadjusted, the large residual variance is explained by the inter-
individual variability remaining due to the omission of other important predictors of 
childhood BMI trajectories. Some of these other predictors, considered to be confounding 
or control variables, were added in the second model. This second model explained a 
further 9% and 7% of the variance in the intercepts and an additional 5% and 6% of the 
variance in the linear component of slope of BMI trajectories for females and males, 
respectively. Since residual variances decreased from the first to the second model, it can 
be concluded that the proposed predictors accounted for some of the inter-individual 
variability in BMI trajectories. Still, residual variances in all trajectory parameters 
remained significant in the adjusted model, reflecting further unexplained inter-individual 
variability.  
In the third model, stratified for females and males by breastfeeding initiation/non-
initiation, interesting changes in variance of trajectory parameters occurred. Among never 
breastfed females, residual variances in the intercept and linear component of slope were 
reduced considerably, while residual variances were increased for the same parameters 
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among breastfed females comparing stratified to unstratified models. This suggests that 
the average adjusted BMI trajectory better represents never breastfed females than it does 
the overall study population of females. Conversely, the average adjusted BMI trajectory 
for females is less representative of the change in BMI among breastfed females in the 
study population.  Among males who were never breastfed, residual variance in the 
intercept is decreased while variance in the linear component of slope is dramatically 
increased. This indicates that while the starting point of the average adjusted BMI 
trajectory may well represent never breastfed males at age 2 years in the study 
population, the slope of the average trajectory is much less representative. The variances 
of the intercept and linear component of slope of BMI trajectories for breastfed males are 
reduced from the unstratified adjusted model, indicating the average adjusted BMI 
trajectory better represents breastfed males in the study population than overall study 
population of males.  
5.1.3 Effects of Prenatal Exposure to GDM on the Shape of Early 
Childhood BMI Trajectories 
5.1.3.1 Overall Effects 
Overall, the results of the current study do not support the existence of a statistically 
significant effect of prenatal exposure to GDM on early childhood BMI trajectories in the 
population studied. The one finding that did reach statistical significance was the effect of 
prenatal exposure to GDM on BMI at age 2 years among males. Exposure to GDM in 
utero was associated with a significant decrease in BMI at age 2 years among males. This 
opposes the original hypothesis that prenatal exposure to GDM is associated with higher 
initial BMI due to over-nutrition and fetal overgrowth. Although these results would 
seem to suggest a potential protective effect of prenatal exposure to GDM on early infant 
weight, the literature does not support such an association. Instead this finding may 
reflect adverse pregnancy outcomes associated with GDM that result in low early infancy 
weight gain, such as spontaneous preterm birth
172
 and gestational hypertension.
143
  
Despite that results were predominantly non-significant, a recurring pattern emerged 
from the model-estimated values of the effect of prenatal exposure to GDM on childhood 
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BMI trajectories. In both unadjusted and adjusted analyses, prenatal exposure to GDM 
appears to be associated with lower BMI at age 2 years followed by an increased rate of 
incline in BMI between the ages of 6 and 10 years for females and males (Figure 4.2). 
Although this overall pattern was neither statistically significant nor consistent with the 
hypothesized effect of intrauterine exposure to GDM on childhood BMI trajectories, it is 
a pattern that mirrors those described in the literature to be predictive of poor health 
outcomes.
8 58 59 61 64-67
 Indeed, this particular pattern mirrors that of catch-up growth, 
described in the literature as initially low weight followed by accelerated early weight 
gain associated with obesity risk and later metabolic disease.
8 58 59 67
  
The goal of studies attempting to identify early life risk factors for child obesity, such as 
intrauterine exposure to GDM, is ultimately to reveal predictors for patterns of childhood 
growth associated with increased risk of later metabolic disease. Indeed, this was the 
intent of the current study. Previous studies that have described patterns in childhood 
growth very similar to those seen in the current study have shown these growth patterns 
to be predictive of adolescent obesity,
59
 adult diabetes,
58 67
 and CHD.
8 58
 These studies all 
found that the greatest metabolic risk  was associated with early growth patterns that 
began with lower than average BMI at birth
8 58
 through age 2 years
58 59 67
 followed by 
higher than average BMI beyond the ages of 6 to 12 years.
8 58 59 67
 In all of these cases it 
is the combination of low initial BMI with a period of accelerated or catch-up growth 
resulting in higher than average BMI that is most strongly predictive of later obesity or 
metabolic disease. Indeed, Eriksson and colleagues
8
 demonstrated an interaction between 
the two factors, showing that lower than average BMI at birth plus rapid childhood 
weight gain is associated with higher risk of death from CHD than either low BMI at 
birth followed by normal weight gain or normal BMI at birth followed by rapid childhood 
weight gain. 
Despite the non-significant findings for the overall effect of prenatal exposure to GDM 
on the shape of childhood BMI trajectories in the current study, some studies suggest the 
patterns of infant and childhood weight gain described above can be seen among 
offspring of mothers with GDM. In terms of initial BMI, GDM is more often associated 
with higher and not lower than average birth weight.
119
 However, treatment for GDM has 
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been shown to reduce rates of high birth weight.
82
 One study even found that the 
offspring of mothers with obstetrically managed GDM had lower than average BMI 
during the first two years, which was followed by accelerated weight gain throughout 
early childhood.
84
 This study also compared mothers with GDM who were treated during 
pregnancy to mothers with untreated mild IGT and revealed steeper weight gain among 
offspring of mothers with GDM beyond the age of 5 years compared to offspring of 
mothers with mild IGT.
84
 Thus, it is theoretically possible that children born to mothers 
with well-managed GDM follow this pattern of low initial BMI and subsequent 
accelerated childhood weight gain. 
5.1.3.2 Indirect Effect through Birth Weight for Gestational Age 
The data do not support a causal model for the effect of intrauterine exposure to GDM on 
early childhood BMI trajectories in which birth weight is an important mediator.  Indeed, 
tests for the indirect effect of prenatal exposure to GDM through birth weight for 
gestational age on BMI trajectory parameters did not reach statistical significance. This 
goes against the hypothesis and suggests that the effect of prenatal exposure to GDM on 
early childhood BMI trajectories is not mediated by birth weight for gestational age. 
However, given that the current study did not reveal a statistically significant direct effect 
of prenatal exposure to GDM on childhood BMI trajectories, it is not surprising that the 
indirect effect was also not found to be statistically significant. A more detailed 
discussion of the reasons for this study’s non-significant findings is provided in Section 
5.2. 
One factor that may have influenced results of the indirect effect is the chosen measure of 
birth weight. The current study assessed the indirect effect of prenatal exposure to GDM 
on BMI trajectories through birth weight in grams adjusted for gestational age. Some 
studies have reported that BMI at birth, that is birth weight adjusted for birth length, is a 
better predictor of later risk of cardiovascular disease than birth weight, even when birth 
weight is adjusted for gestational age.
8 173
 Since BMI at birth can predict later 
cardiovascular health, it is possible that it may also predict the childhood growth patterns 
that are also predictive of cardiovascular and metabolic health. Thus, BMI at birth may 
have been a better choice as a mediator for the effect of prenatal exposure to GDM on 
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BMI trajectories than birth weight for gestational age. 
5.1.4 Effects of Breastfeeding 
Previous studies have suggested that breastfeeding may have protective effects against 
the development of childhood obesity.
46 99 102-108 110 174
  In this study, stratified analyses 
examining the potential modifying effects of breastfeeding revealed no statistically 
significant modification of the effects of prenatal exposure to GDM on early childhood 
BMI trajectories. Indeed, the differences in the model-estimated effect of prenatal 
exposure to GDM on BMI trajectories between breastfeeding groups were found to be 
non-significant. Possible reasons for these non-significant findings are discussed in 
Section 5.2. The remainder of the current subsection discusses the patterns that emerged 
from model-estimated values of the effects of prenatal exposure to GDM and 
breastfeeding on BMI trajectories in context of the pertaining literature. Although the 
results were not statistically significant, the shapes of modelled BMI trajectories in the 
stratified analyses reflect patterns in early childhood weight gain associated both with 
prenatal exposure to GDM and breastfeeding that mirror patterns predicted in initial 
hypotheses as well as those described in the literature. 
5.1.4.1 Breastfeeding as a Protective Factor against Childhood 
Obesity Risk 
Although there were no statistically significant differences between breastfeeding groups, 
the values of model estimates mirror patterns in past studies that have shown 
breastfeeding is associated with lower BMI in infancy,
99 101 106 174
 early childhood,
46 104 105 
108
 and later childhood.
102 103 110
 Overall, regardless of whether or not children were born 
to mothers who had GDM, breastfeeding appears to be associated with overall lower BMI 
throughout childhood. This is consistent with studies that have shown that breastfeeding 
is associated with less early infancy weight gain
99 101 106 174
 as well as reduced BMI 
throughout childhood.
46 102-105 108 110
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5.1.4.2 Breastfeeding as a Modifier for the Association between 
Intrauterine Exposure to GDM and Childhood BMI 
Trajectories 
The results of the current study do not support breastfeeding as a modifier of the effect of 
prenatal exposure to GDM on childhood BMI trajectories. However, it may be interesting 
to note that model-estimated values of the effect of intrauterine exposure to GDM on 
BMI trajectories appear markedly different depending on breastfeeding status. Never 
breastfed females who were exposed to GDM in utero have an estimated BMI trajectory 
that appears initially low with early and rapid catch-up growth resulting in a rate of 
incline in BMI that surpasses the rate of their non-exposed counterparts between the ages 
of 6 and 10 years (Figure 4.3; Top left). Conversely, ever breastfed females who were 
exposed to GDM in utero have a BMI trajectory that begins similarly low but rises more 
steadily between the ages of 4 and 10 years (Figure 4.3; Top right). In the breastfed 
group, females with prenatal exposure to GDM marginally surpass BMI of their non-
exposed counterparts only by the age of 10 years.  Thus, breastfeeding appears to be 
associated with an attenuation of the effects of prenatal exposure to GDM on the initial 
level and rate of incline of BMI trajectories among females. Other studies have reported 
an association between breastfeeding and slower infancy and early childhood weight 
gain.
101 106
 These studies have shown that never breastfed infants experience accelerated 
weight gain in the first few years of life while breastfed infants exhibit less weight gain 
during the same period.
101 106
 Although these studies describe very early weight gain 
(birth to age 2
106
 and birth to age 3 years
101
), there is reason to believe breastfeeding may 
have an important influence on later childhood weight trajectories. Indeed one study 
demonstrated that among 3 to 6 year-olds, breastfeeding was associated with better 
appetite regulation and higher responsiveness to satiation,
100
 which, continuing into later 
childhood, may explain more gradually inclining BMI. 
The pattern seen among males in the study sample appears even more pronounced. The 
estimated BMI trajectory for never breastfed males who were exposed to GDM in utero 
begins significantly lower than that of non-exposed males in the same group with very 
early and rapid catch-up growth between the ages of 4 and 10 years (Figure 4.3; Bottom 
left). Never breastfed males who were exposed to GDM prenatally eventually surpass 
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BMI of their non-exposed counterparts by the age of 10 years.  Although the pattern in 
BMI trajectories among never breastfed males shares similarities to the pattern seen 
among never breastfed females in the study, the pattern among breastfed males is 
markedly different. Comparing never breastfed to breastfed females, initial BMI is 
decreased among those exposed to GDM in utero and is followed by a steep incline in 
BMI until the age of 10 years. However, comparing never breastfed to breastfed males, 
initial BMI appears to increase among those exposed to GDM prenatally followed by a 
rate of incline in BMI throughout childhood similar to non-exposed breastfed males 
(Figure 4.3; Bottom right). Breastfed males who were exposed to GDM in utero also 
appear to experience later adiposity rebound (AR at 6 years) than both never breastfed 
males exposed to GDM (AR at 4 years) and breastfed males not exposed to GDM (AR 
between 4 and 6 years).   
Although these findings are not statistically significant and interpretations must be drawn 
with caution, they do follow a pattern consistent with studies that have shown both that 
breastfeeding is associated with lower childhood BMI
46 102-105 108 110 175
 and that it is most 
strongly associated with reduction of obesity risk among children with pre-existing risk 
factors.
107 108 112
 A study by Buyken and colleagues
107
 that examined the association 
between breastfeeding and percent body fat trajectories in early childhood found a 
significant protective effect of breastfeeding in males with overweight mothers but not in 
males with normal weight mothers. Furthermore, this study proposed an interaction effect 
between maternal overweight and breastfeeding. 
107
 This suggests that the particular risk 
profiles of children may modify and, in some cases, enhance the protective effect of 
breastfeeding. If this concept is applied to the interpretation of results in the current 
study, it would suggest that breastfeeding may be a particularly effective strategy to 
prevent adverse childhood weight outcomes associated with prenatal exposure to GDM 
for males.  
5.2 Non-Significant Study Findings 
The objective of the current study was to examine the impact of prenatal exposure to 
GDM on early childhood BMI trajectories with the hypotheses that exposure to GDM 
would be associated with initially high BMI as well as high rising BMI throughout 
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childhood. It was also hypothesized that breastfeeding would attenuate this association, 
as previous studies have shown that breastfeeding has protective effects against the 
development of overweight and obesity. However, the results of the analyses were mainly 
non-significant. Model results for the estimated effect of prenatal exposure to GDM on 
childhood BMI trajectories either did not reach statistical significance or did not support 
the hypotheses. Results of models examining effect modification by breastfeeding also 
did not reach statistical significance. There are a number of possible reasons that the 
study findings differed from expectations. This subsection focuses on issues related to the 
study design that may have contributed to these non-significant study findings.  
5.2.1 Identification of Exposure 
One issue that may have contributed to the overall non-significant study findings is the 
possibility of only partial identification of the exposure of interest. In the current study 
the exposure of interest was GDM, which was measured by maternal report of diabetes 
diagnosis during pregnancy. Although studies have reported GDM as a risk factor for 
various adverse child weight outcomes, many of these studies were able to identify GDM 
diagnosis through data from clinical measures such as oral glucose tolerance test (OGTT) 
results
75-77 83 84 91-93
 and average daily glycemia.
76
 While some studies have also used 
maternal report to identify GDM in study populations,
81 176
 this measure certainly 
contains less information about the actual exposure to the fetus than clinical measures. 
Indeed, self-reported GDM diagnosis does not per se provide information about the 
degree to which blood sugar levels are managed throughout pregnancy or the chosen 
method of blood sugar management. These variables undoubtedly alter the amount of 
fetal exposure to a hyperglycemic prenatal environment. In current clinical practice, 
patients with GDM are often given intensive treatment to manage blood sugar levels 
during pregnancy.
177-180
 Thus, it is possible that mothers in the NLSCY study population 
truly represented a group with well managed glycemia during pregnancy due to intensive 
obstetric care.  
A related issue to the insufficient identification of the exposure of interest due to the 
unavailable information on actual maternal glycemia during pregnancy is that the study 
population likely included those with undiagnosed gestational hyperglycemia. Indeed, 
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insulin resistance is common even in normal pregnancy,
180
 and many women experience 
levels of gestational hyperglycemia that do not meet diagnostic criteria for GDM.
181
 Few 
studies have examined the effect of treatment for mild gestational hyperglycemia
181
 and 
many women with mild hyperglycemia during pregnancy may not receive proper 
treatment to manage blood glucose levels.  
In the current study population, there may have been individuals that did not meet the 
criteria for GDM diagnosis, but nevertheless experienced a significant level of 
hyperglycemia during pregnancy. However, these cases would not have self reported 
pregnancy diabetes in the NLSCY because of a lack of clinical diagnosis. This group 
would thus represent a truly at-risk population of children exposed to a hyperglycemic 
prenatal environment due to potentially untreated maternal hyperglycemia during 
gestation. The data used in the current study did not contain any further measures of 
maternal glucose tolerance during pregnancy beyond the question of whether or not 
mothers were diagnosed with GDM. Therefore, an important portion of the population at 
risk was not captured in the current study. This may have contributed to the non-
significant study findings, as the unexposed population likely contained many cases in 
which children were in fact exposed to undiagnosed maternal hyperglycemia in utero. If 
this is the case, the model estimates of the impact of prenatal exposure to GDM on 
childhood BMI trajectories were based on differences between two groups that each 
contained similar cases, which would inevitably result in null findings. Furthermore, the 
finding that males exposed to GDM in utero had significantly lower initial BMI than 
unexposed males may only reflect the difference in outcomes of pregnancies that 
consistently involved treatment for blood glucose management versus pregnancies that 
did not. 
5.2.2 Obstetric Management of GDM  
To further complicate matters, the treatment of GDM is not necessarily standardized 
since management strategies used in practice are not all evidence-based in terms of both 
efficacy and minimization of adverse perinatal outcomes.
177-180
 For example, although 
dietary counselling is the first line of treatment for many cases of GDM,
177
 nutritional 
guidelines to achieve and maintain appropriate glycemic control are not evidence-based 
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due to limited research available on specific nutritional recommendations.
180
 
Furthermore, women diagnosed with GDM can range in level of hyperglycemia from 
levels that would constitute diabetes diagnosis outside of pregnancy to levels that do not 
cause symptoms but have adverse effects on the fetus.
180
 In clinical practice, treatment 
options for GDM vary according to blood glucose levels, but decisions are based more on 
expert opinion and usual practice rather than research evidence.
177
 Thus, there may be 
wide variation in terms of level and duration of hyperglycemia during pregnancy even 
among women diagnosed with GDM and receiving treatment.     
A Cochrane review
178
 of studies examining the perinatal outcomes associated with 
various GDM management strategies found that treatment with insulin is associated with 
a higher risk of labour induction and Caesarean section than treatment with oral 
hypoglycemic medication.
178
 Pregnancy complications such as these may explain why 
the current study found prenatal exposure to GDM to be associated with childhood BMI 
trajectories that are initially lower than those of children who were not exposed to GDM.  
In summary, the study findings for the association between prenatal exposure to GDM 
and childhood BMI trajectories differed from expectations due, in part, to the inability to 
define the exposure group in terms of the actual exposure. Indeed, data on maternal GDM 
diagnosis did not provide enough information about prenatal exposure to maternal 
hyperglycemia to conclude all children in the exposure group were similarly exposed. 
Further, intensive obstetric care and potentially tight control of blood glucose levels 
during pregnancy may have ensured that the group of children defined by GDM exposure 
actually had less exposure to maternal hyperglycemia in utero than others in the study 
population. 
5.3 Study Limitations 
5.3.1 Self-Reported Data 
The inherent limitations of self-reported data reflect one of the main drawbacks of the 
current study. Indeed, as previously discussed, self-reported GDM diagnosis does not 
contain enough information to comment on level of fetal exposure to maternal 
hyperglycemia. Information on child height and weight used to calculate BMI was also 
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reported and not measured directly in the NLSCY. Self-report of these physical measures 
limit the accuracy of analyses using these data. However, the focus of the current study 
was on the shape of childhood BMI trajectories. Assuming that inaccuracies in maternal 
report of child height and weight were relatively consistent throughout cycles, this 
limitation has minimal influence on the interpretation of study findings. The accuracy of 
maternal report of birth weight and gestational age may have influenced study results 
given that recall of these measures likely varied with the age of the child at the time of 
the interview.  
5.3.2 Sample Size and Attrition 
The inability to detect statistically significant effects of prenatal exposure to GDM on 
childhood BMI trajectories may be due, in part, to small sample sizes and attrition. 
Indeed, the numbers of females and males exposed to GDM in the study sample were 
small to begin with, only 73 and 127, respectively.  These numbers were further reduced 
in analyses stratified by breastfeeding history. The large rates of attrition in the 
longitudinal cohort of the NLSCY also limit the power to detect significant effects. 
Indeed, as cycles progressed there was greater attrition. Thus, estimates for the linear and 
quadratic components of slope of BMI trajectories were based on progressively fewer 
cases over time.  
5.3.3 Maternal Characteristics 
The current study is limited by the information available in the NLSCY on maternal 
characteristics.  One of the most important maternal characteristics that was not captured 
by the survey is maternal pre-pregnancy BMI. Indeed, studies have shown that maternal 
BMI is a strong predictor of birth weight as well as childhood weight status, with higher 
pre-pregnancy BMI being associated with higher risk of childhood overweight and 
obesity.
182 183
 Furthermore, as previously discussed, high pre-pregnancy BMI is 
associated with higher risk of GDM,
130
 and thus most studies examining the association 
between GDM and child weight status control for maternal BMI.  Although this 
information was unavailable for the current study, the NLSCY provides the only 
nationally representative Canadian data currently available to examine childhood BMI 
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longitudinally. While proxy variables for maternal overweight were used in adjusted 
analyses, there is nevertheless the possibility that patterns seen in the study results may 
reflect the impact of maternal BMI, and not prenatal exposure to GDM, on childhood 
BMI trajectories.   
As mentioned previously, GDM is difficult to ascertain in population studies using self-
reported diagnosis.  The methodological issue with self-reported GDM already discussed 
is that it may truly reflect previously undiagnosed diabetes mellitus (DM).
151
 Although 
this did not pose a threat to the current study for reasons already discussed, other 
methodological issues in assessing GDM diagnosis complicate the interpretation of study 
results.  In a review of studies on the prevalence of GDM, Ferrara
151
 discusses one 
prevailing issue with assessing GDM trends in populations which has been that OGTT 
for GDM that use different criteria for interpretation arrive at different diagnoses.  
Therefore, self-reported GDM diagnosis may not have captured all cases of GDM in the 
study population, as there may have been cases in which GDM was undiagnosed due to 
the use of different diagnostic criteria.   
Finally, in terms of the limitations in available maternal data, the NLSCY did not contain 
information to isolate those who did not have a GDM diagnosis but had DM prior to 
pregnancy. Therefore, the unexposed group in the study population may have contained 
individuals born to women with DM. This poses the problem that children born to 
women with DM are not likely to have the same level of obesity risk as children born to 
women with normal glucose tolerance. Indeed, many studies either treat offspring of 
diabetic mothers separately from offspring of nondiabetic mothers and offspring of 
mothers with GDM
75 78 87 88 93
 or exclude this group entirely when examining the effect of 
prenatal exposure to GDM on child weight status.
81 83 86 92
 
5.3.4 Breastfeeding and Early Nutrition 
Due to the small sample sizes, it was not feasible to divide breastfeeding categories any 
further than the two categories defined by breastfeeding initiation. However, many 
studies have shown that, once initiated, the duration and consistency of breastfeeding has 
important and varied effects on later childhood growth.
46 99 101 105-110
 Thus, group defined 
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in this study as having ever been breastfed is a less homogenous group than those who 
were never breastfed, which likely lead to the non-significant model results among 
breastfed children. Also the data did not contain information on early nutrition, and in 
particular, the timing of introduction of solid foods, which also has important impacts on 
child weight and weight gain.
111
  
5.4 Study Strengths 
The current study is one of the first to investigate the child obesity problem in Canada by 
assessing prenatal predictors of BMI trajectories for a large, nationally representative, 
longitudinal sample of Canadian children using LGCM. Robust population-level data 
produced through the strong sampling design of the NLSCY were analyzed in this study 
with an equally strong statistical technique designed to handle longitudinal data.  Despite 
non-significant findings, this thesis provides a framework for future research on 
childhood growth trajectories that can be used with improved datasets, variables, and 
theoretical models. This section details the strengths of the current study in terms of the 
analytic approach and dataset and discusses the importance of this study as a foundation 
for future pediatric overweight and obesity research.  
5.4.1 Analytic Approach 
One of the major strengths of this study is the analytic approach to assessing prenatal 
exposure to GDM as a predictor of child weight. While many studies have examined the 
relationship between exposure to GDM in utero and child weight status measured at a 
single point in time, the current study examined the impact of this exposure on 
trajectories of growth.  As discussed previously, the analysis of longitudinal patterns of 
growth provides greater insight into child health than analyses of weight status alone by 
revealing timing of developmental events, early growth patterns, and rates of growth.
8 61 
64-66
 Studies that examine weight status at a single point in childhood or adolescence omit 
important information on the patterns and rates of growth from infancy that have been 
shown to be predictive of future health status.  The current study allowed observation of 
the impact of prenatal exposure to GDM on BMI in infancy, timing of adiposity rebound, 
and the rate of incline in BMI throughout early childhood.  While each of these 
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characteristics of early growth has been shown to have important implications for later 
overweight and obesity, it is the combination of these characteristics that conveys the 
most meaning when evaluating the risk of obesity and future metabolic disease. Indeed, 
these observations, considered together as growth patterns, provide the very best insight 
into child health.  
The statistical technique chosen for this thesis is the best method currently available to 
analyze these complex growth patterns.  Indeed, LGCM is an advanced statistical 
technique that allows repeated observations to be treated not just as multiple related data 
points to be assessed on the individual and group levels, but as a single continuous 
phenomenon for each individual.  It is for this reason that this was the most appropriate 
analytic approach to address the research questions in this thesis. As LGCM is based in 
structural equation modelling (SEM), this permitted designing a causal model that could 
simultaneously address direct and indirect effects of the exposure of interest on BMI 
trajectories while also adjusting for other upstream predictors.  Indeed, SEM-based causal 
models take into account the timing of impact of different predictors as well as 
relationships between them, resulting in a more realistic theoretical framework.  
The explicit treatment of missing data in analyses reflects another one of this study’s 
analytical strengths.  Indeed, missing data is a persistent issue with panel data due to the 
inevitability of attrition in longitudinal data collection. The statistical software used to 
conduct analyses in this study, Mplus,
162
 was designed for longitudinal data analysis and 
offers a number of options for missing data adjustment. As described previously, missing 
data were adjusted using FIML estimation, which is a method that has been shown to 
outperform other missing data methods in terms of efficiency and bias.
165
  While other 
methods to deal with missing data in SEM-based analyses involve atheoretical deletion of 
cases with missing values (e.g. listwise deletion, pairwise deletion), FIML is based in 
theory and uses all available observed data to adjust for missing values and produce 
unbiased parameter estimates in MAR data conditions.
165
  
5.4.2 Dataset  
This study used a large dataset that contained population level data that was collected 
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using a strong, complex sampling design, as described in Section 3.1.2.  This sampling 
design resulted in a nationally representative sample population, and thus the use of this 
dataset in the current study ensured study results would be relevant and generalizable to 
the Canadian pediatric population.  
5.4.3 Groundwork for Future Research 
As more studies begin to utilize longitudinal data to assess early-life predictors of 
childhood overweight and obesity, there will likely be more research conducted with the 
objective of examining rates and patterns of childhood growth.  As more longitudinal 
childhood health data become available, there will also be more opportunities to conduct 
this type of analysis.  Currently, few studies have used LGCM in the context of pediatric 
obesity research.  However, the growing interest in how patterns of childhood growth 
predict later weight and health outcomes will necessitate more research using this 
analytic technique. Since the use of growth curve modelling using latent variables is 
relatively novel in epidemiological research, studies such as this one will help to lay the 
groundwork for future childhood obesity research.  Indeed, future studies can utilize the 
framework of the current study to address similar research questions by using new 
datasets, linking current datasets to hospital records containing more accurate maternal 
and child health information, and improving on the theoretical model as new variables 
become available.  
5.5 Conclusions and Recommendations  
This study took an analytic technique for longitudinal data not commonly used in child 
obesity research to assess important prenatal risk factors for childhood BMI.  With the 
epidemic of childhood obesity and the ever-growing prevalence of obesity-related 
metabolic disorders among children, the focus of pediatric obesity research has been 
shifting to causal mechanisms for obesity present earlier and earlier in development. The 
current study sought to examine prenatal contributions to the development of childhood 
overweight and obesity by looking at the effects of prenatal exposure to gestational 
diabetes mellitus on childhood BMI trajectories. Although the study findings did not 
reach statistical significance, interesting patterns emerged from the estimated models that 
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may warrant further investigation. Future research in this area must use data that contains 
complete maternal pre-pregnancy information and a study design that also accounts for 
postnatal factors in order to arrive at conclusions that have potential clinical and 
therapeutic value. Nevertheless, this study highlights the fact that early childhood growth 
is complex and studies that attempt to assess predictors of unhealthy childhood growth 
should examine child weight outcomes in context of this complexity.   
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Appendix A: Summary of previous studies examining the association between 
maternal impaired glucose tolerance (IGT) and weight status of offspring.  
 
Author(s)
/Year 
Study 
Information 
Population 
Characteristics 
Sample 
Size 
Measure of 
Maternal IGT 
Child Weight 
Outcome/ 
Measure 
Measure of 
Association 
Estimate of Association 
between Maternal IGT and 
Child Weight Outcome 
Boersch-
mann et 
al. 75 
/2010 
Germany – 
Prospective 
German GDM 
offspring study 
(GDM study) and 
BABYDIAB study 
(1989-2000) 
Children born to 
mothers with GDM 
(OGDM), mothers 
with type I diabetes 
(OT1D), and 
nondiabetic mothers 
(ONDM) followed 
from <1 to 14 years 
of age 
1,420 75-gram Oral 
Glucose 
Tolerance 
Test (OGTT; 
from GDM 
study)/ Type I 
diabetes 
status (from 
BABYDIAB 
study) 
Overweight at 
age 2, 8, and 
11 years (BMI 
≥ 90th 
percentile)/ 
weight and 
height 
measured by 
physicians at 
clinic visits 
Percent 
increase in 
obesity 
prevalence 
due to GDM 
exposure  
Increase in overweight at 
age 2, 8, 11 comparing 
OGDM to OT1D and 
ONDM: 31.1%, 15.8%, 
15.5% (p = 0.05) 
Buzinaro 
et al.76 
/2008 
Brazil - Obstetrics 
Hospital of the 
Faculty of 
Medicine of 
Botucatu 
(HCFMB) 
Obstetric Service 
(1988-1999) 
Pregnant women 
who participated in 
previous HCFMB 
studies and their 
children  
73 Normal, 
hyperglyc-
emic, or 
GDM defined 
by OGTT & 
daily 
glycemia 
(American 
Diabetes 
Society & 
Brazilian 
Guidelines on 
Dyslipidemia)  
Weight at 
birth and 
overweight in 
adolescence 
(BMI ≥ 85th 
percentile)/ 
Neonatal 
questionnaire 
and 
anthropomet-
ric measures  
Comparison 
between 
groups using 
ANOVA and 
Goodman 
test 
Birth weight: Higher in 
offspring of GDM mothers 
3667 ± 527 g) than 
hyperglycemic and control 
mothers (3282 ± 401 and 
3167 ± 565 g) p<0.05 
 
Overweight: More 
offspring of GDM mothers 
overweight compared to 
control (52.2% vs 14.8%) 
p<0.05  
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Catalano 
et al. 77 
/1995 
United States 
(Vermont) - 
Longitudinal 
study of 
carbohydrate 
metabolism 
before and during 
early and late 
gestation (1984-
1990) 
Healthy, non-obese, 
non-smoking 
women with either 
normal glucose 
levels prior to 
pregnancy and 
GDM/abnormal 
glucose tolerance 
during pregnancy or 
normal throughout 
16 GDM 
diagnosis or 
at least one 
abnormal 
glucose 
tolerance 
test score 
Neonatal 
growth/ birth 
weight, fat 
mass 
Coefficient of 
determin-
ation (R2) 
(Maternal 
insulin 
sensitivity 
before/ 
during 
pregnancy) 
Birth weight and insulin 
sensitivity during 
pregnancy: R2 = 0.48* 
 
Fat mass and insulin 
sensitivity before 
pregnancy: R2 = 0.46* 
 
*Adjusted for significant 
independent variables 
Cho et 
al.78 
/2000 
United States – 
The Diabetes in 
Pregnancy Center 
(Northwestern 
University) 
longitudinal study 
of maternal 
metabolism 
(1977-1983) 
Offspring of mothers 
with GDM or 
pregestational 
diabetes (PGDM) 
and offspring of 
control mothers 
with no abnormal 
glucose tolerance 
during pregnancy 
179 GDM or 
PGDM 
diagnosis 
BMI at ages 
10 to 16/  
measured 
height and 
weight 
Difference in 
average BMI 
score 
comparing 
offspring of 
GDM/PGDM 
mothers with 
control 
mothers 
Average BMI* in 
OGDM/OPGDM: 22.5 ± 5.6  
Average BMI* in offspring 
of control mothers: 20.5 ± 
4.0 
(p<0.005) 
*Controlled for age and 
sex 
Crume et 
al. 15 
/2011 
United States 
(Colorado) – 
Exploring 
Perinatal 
Outcomes in 
Children (EPOCH) 
Study (1992-
2002) 
Singleton children 
aged 6 to 13 
exposed to GDM 
and random sample 
not exposed to GDM 
461 GDM status 
(positive/ 
negative) 
from health 
insurance 
company 
perinatal 
database 
Adiposity, fat 
distribution/ 
BMI, waist 
girth, skinfold 
thickness, 
MRI 
measured by 
researchers 
Average 
difference 
(measures) 
comparing 
GDM to no 
GDM 
BMI: 1.3 kg/m2 higher 
(p=0.02) 
Waist: 4.2 cm larger 
(p=0.004) 
Visceral, subcutaneous, 
and central fat: higher 
(p=0.01) 
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Dabelea 
et al. 79 
/2000 
United States 
(Arizona) – 
Longitudinal 
study of diabetes 
and related 
complications 
(1965) 
Pima Indian families 
with two or more 
non-diabetic 
children; ≥1 child 
born prior to 
maternal diabetes 
diagnosis and ≥1 
child born after 
(same father)  
183 Diabetes 
diagnosed 
with 75-gram 
OGTT 
according to 
WHO (1985) 
criteria 
(Medical 
history) 
BMI at age 
13/ recorded 
height and 
weight  
Mean 
difference in 
BMI between 
siblings 
exposed to 
diabetes and 
unexposed 
BMI at age 13: 2.6 kg/m2 
(95% CI: 0.9-4.3 kg/m2) 
higher comparing siblings 
exposed to maternal 
diabetes to siblings 
unexposed to it 
(controlled for sibship) 
Deierlein 
et al.80 
/2011 
United States – 
Pregnancy 
Infection and 
Nutrition (PIN) 
study (2001-
2008) 
Pregnant women 
receiving prenatal 
care from University 
of North Carolina 
Hospitals who 
delivered live, 
singleton infants 
263 Blood 
glucose 
concentra-
tion 
categories: 
<100, 100-
<130, ≥130 
mg/dL 
Overweight at 
age 3 years 
(BMI≥85th 
percentile)/ 
height and 
weight 
measured by 
PIN staff 
Risk ratio for 
overweight 
comparing 
offspring of 
mothers with 
≥130 versus 
<100 mg/dL  
2.34 [95% CI: 1.25-4.38] 
adjusted for maternal 
education, race, prenatal 
smoking, prepregnancy 
BMI, and 
maternal height 
Gillman 
et al.81 
/2003 
United States – 
Growing Up 
Today Study 
(1996)/Nurses’ 
Health Study II  
Children of female 
registered nurses 
aged 9-14 years; 
Important 
exclusions: Mothers 
with pre-existing 
diabetes, children 
with diabetes 
14,881 Maternal 
report of 
diabetes 
diagnosed 
during index 
pregnancy 
(GDM) 
Overweight at 
age 9-14 
years (BMI > 
age- and sex-
specific 95th 
percentile)/ 
child self-
reported 
height, weight 
Odds Ratio of 
overweight 
comparing 
GDM to no 
GDM   
1.4 [95% CI 1.0–1.9] – 
unadjusted 
 
1.2 [95% CI 0.8–1.7] – 
adjusted for birth weight 
and maternal BMI 
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Gillman 
et al. 82 
/2010 
Australia – 
Australian 
Carbohydrate 
Intolerance 
Study in Pregnant 
Women 
(ACHOIS)/ 
Children, Youth 
and Women’s 
Health Service 
(CYWHS)  
Mothers with mild 
GDM who 
participated in 
ACHOIS trial and 
their singleton 
children aged 4-5 
years who were 
linked to CYWHS 
surveillance data 
199 Random 
assignment 
to Routine 
care versus 
treatment for 
mild GDM 
(through 
ACHOIS trial) 
Macrosomia 
at birth and 
BMI ≥ age- 
and sex-
specific 85th 
percentile at 
age 4-5 years/ 
recorded 
height and 
weight 
measures by 
CYWHS  
Percent/ BMI 
Z-score 
difference 
between 
routine and 
treatment 
groups 
Macrosomia at birth: 
21.9% in routine care 
group (n=105) and 5.3% in 
treatment group (n=94) 
 
BMI at age 4-5 years: no 
significant difference 
between groups 
Hillier et 
al. 83 
/2007 
United States –
Kaiser-
Permanente 
Hawaii (KPH) and 
Kaiser 
Permanente 
Northwest 
(KPNW) 
Membership 
databases 
Singleton births at 
KPH/KPNW between 
1995 and 2000; 
Important 
exclusions: Mothers 
with pre-existing 
diabetes 
9,439 Most recent 
GDM 
screening 
test result 
from 
KPH/KPNW 
medical 
records 
Overweight at 
age 5-7 years 
(weight ≥ 85th 
and 95th age- 
and sex-
specific 
percentiles) 
/measured 
weight in 
records 
Odds ratio of 
overweight 
comparing 
higher 3 
quartiles of 
glucose 
challenge 
test scores to 
lowest 
quartile 
1.28 (95% CI 1.02-1.60) 
comparing highest quartile 
of GCT score to lowest 
Lee et 
al.84 
/2007 
Korea –  
Il-Shin Christian 
General Hospital; 
Ajou, Seoul 
National, and 
Pochon Cha 
University 
Hospitals  
Women with 
diagnosed GDM or 
impaired glucose 
tolerance (IGT) and 
their children 
recruited in the 
hospital study 
298 GDM or IGT 
determined 
by 50 g 
glucose 
challenge 
test followed 
by 3h OGTT 
BMI from 
measured 
height and 
weight for 
children aged 
3 to 5 years 
Comparison 
of mean BMI 
between 
offspring of 
GDM versus 
IGT mothers 
BMI at age ≥5 years:  
OGDM: 16.9 kg/m2 (95% 
CI, 16.2–17.4) 
OIGT: 15.2 kg/m2 (95% CI, 
14.3–16.1) 
p<0.01 
No significant differences 
between groups at ages 3 
and 4 years 
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Lindsay 
et al.85 
/2000 
United States – 
(Arizona) 
Epidemiological 
survey of Gila 
River Indian 
Community 
(1955-1994) 
Pima and Tohono 
O’odham Indian 
women between 
with Type 2  
diabetes (DM), no 
diabetes (NDM), and 
prediabetes (PDM) 
2096 Pre-
pregnancy  
diabetes 
diagnosis 
(DM), or 
diabetes 
arising within 
10 years 
(PDM) 
Birth weight 
and BMI from 
5 to 30 years 
of age/ 
hospital 
records and 
research 
examinations 
Comparison 
of birth 
weight and 
age- and sex-
adjusted BMI 
between 
offspring of 
DM, NDM, 
and PDM  
Birth weight significantly 
higher in ODM: ODM 3724 
± 52 g, OPDM 3,541 ± 41 
g, ONDM 3,408 ± 11 g; p< 
0.05  
BMI significantly higher 
comparing ODM to both 
ONDM and OPDM from 
age 5 to 19 years  
Pettit et 
al. 86 
/1985 
United States – 
(Arizona) Gila 
River Indian 
Community of 
Arizona and 
Sacaton/Phoenix 
Indian Health 
Service hospitals 
Pima Indian women 
with no previous 
diabetes diagnosis 
and their offspring 
with recorded 
pregnancies 
between 1965 and 
1984 
1049 Pregestation-
al diabetes 
(PGDM), 
normal GT 
(<140 mg/dL 
blood 
glucose), or 
abnormal GT 
(≥140 mg/dL 
blood 
glucose) 
Percent 
desirable 
weight at age 
5-19 years/ 
child weight 
divided by the 
50th 
percentile 
sex- and age-
specific 
weight for 
height 
Comparison 
of percent 
desirable 
weight 
between 
offspring of 
mothers in 
three blood 
glucose 
groups 
Significantly higher 
percent desirable weight 
at ages 5-9 and 10-14 
years comparing offspring 
of mothers with abnormal 
GT or PGDM to offspring 
of mothers with normal 
GT, controlling for 
maternal obesity 
Plage-
mann et 
al. 41 
/1997 
Germany (Berlin) 
– Department of 
Neonatology of 
the Clinic of 
Obstetrics and 
Gynaecology in 
Berlin-Kaulsdorf 
Children born 
between 1980 and 
1990 to diabetic 
mothers with 
available 
developmental data 
317 Insulin 
dependent 
diabetes 
mellitus 
(IDM) and 
GDM 
Birth weight 
and size and 
BMI at age 1 
to 9 years/ 
recorded 
data, 
measures 
taken during 
study 
Percent SGA, 
AGA, LGA,  
overweight, 
and obese  
No significant differences 
between IDM and GDM 
groups, but both groups 
showed high frequency of 
high birth weight and LGA 
in infancy and overweight, 
and obesity in childhood 
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Silver-
man et 
al. 87 
/1993 
United States 
(Illinois) – 
Prospective 
longitudinal study 
using Diabetes in 
Pregnancy Center 
(1977-1983) 
Pregnant women 
with GDM, 
pregestational 
diabetes (PGDM), or 
no diabetes and  
their offspring  
242 GDM or 
pregestation-
al diabetes 
(PGDM) 
diagnosis 
Birth weight 
and BMI from 
age 3 months 
to 8 years/ 
measures 
taken during 
study 
Comparison 
of BMI 
growth 
curves to 
national 
standards 
Offspring of GDM/PGDM 
women higher BMI from 
age 6 to 9 compared to 
national standards with 
average BMI at 90th 
percentile of general 
population 
Silver-
man et 
al. 88 
/1998 
United States 
(Illinois) – 
Prospective 
longitudinal study 
Diabetes in 
Pregnancy Center 
(1977-1983) 
Pregnant women 
with GDM, 
pregestational 
diabetes (PGDM), or 
non-diabetic and  
their offspring 
? GDM or 
PGDM 
diagnosis and 
amniotic fluid 
insulin (AFI) 
concentra-
tion 
BMI from 
infancy to age 
17 years/ 
Yearly 
height/weight 
measures  
Mean BMI at 
age 14-17 in 
children of 
GDM/PGDM 
versus 
control 
women 
Mean BMI at age 14-17 
years in children of 
GDM/PGDM women: 24.6 
± 5.8 kg/m2 (versus 
control at 20.9 ± 3.4 
kg/m2; p<0.001) 
Tallarigo 
et al.89 
/1986 
Italy – National 
Research Council 
Clinical 
Physiology 
Institute, 
Obstetrical clinic 
(1981-1983) 
Pregnant women 
tested at the 
obstetrical clinic and 
given an oral glucose 
tolerance test 
(OGTT) 
249 Three levels 
of maternal 
plasma 
glucose at 
third 
trimester: 
<100 mg/dl, 
100-119 
mg/dl, and 
120-164 
mg/dl 
Macrosomia 
at birth 
Test for 
linear trend 
between 
maternal 
plasma 
glucose level 
and 
frequency of 
macrosomia 
Percent macrosomia: 
<100 mg/dl: 9.9%,  
100-119 mg/dl: 15.5%, 
120-164 mg/dl: 27.5% 
 
p<0.01 
110 
 
Tam et 
al. 90 
/2010 
China (Hong 
Kong) – 15-year 
follow-up study 
of cardio-
metabolic risks in 
adolescents 
(originally 
recruited in 1992-
1994) 
Adolescents aged 15 
years who were part 
of an cohort of 
children born to 
women with GDM 
and age-matched 
controls who were 
examined at 8 years 
of age in a previous 
study 
129 In utero 
hyperinsulin-
emia 
measured by 
C-peptide 
and insulin 
levels in 
umbilical 
cord blood 
Overweight 
(age- and sex-
specific BMI 
≥90th 
percentile)/ 
Height and 
weight at age 
15 measured 
during study 
Odds Ratio of 
overweight 
at age 15 
comparing 
those 
exposed/un-
exposed  to 
hyperinsulin-
emia in utero 
(measured 
two ways) 
In utero hyperinsulinemia 
measured by 
Cord blood insulin level: 
7.66 (95% CI 1.32-44.5)  
Cord blood C-peptide 
level: 10.8 (95% CI 1.69-
69.2) [both adjusting for 
birth weight, maternal 
BMI, maternal GDM status 
and Tanner stage] 
Villa-
Caballero 
et al. 176 
/2009 
United States 
(California) - 
Randomized 
community 
intervention for 
healthy eating 
and physical 
activity 
Children in grades K 
to 2 and their 
mothers recruited 
for healthy 
eating/physical 
activity study 
(predominantly 
Latino) 
725 Maternal 
report of 
diabetes 
diagnosis and 
GDM during 
index 
pregnancy 
Child BMI and 
overweight 
status (age- 
and sex-
specific BMI 
and CDC BMI 
cut-offs)/ 
Measured 
weight and 
height 
collected in 
original study 
Odds Ratio of 
normal 
weight 
comparing 
children 
whose 
mothers had 
GDM to 
children 
whose 
mothers did 
not have 
GDM 
Children of mothers with 
GDM had OR of 0.32 of 
being normal weight, 
adjusted for age, 
education, employment 
status, and marital status 
(p<0.05) 
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Vohr et 
al.91 
/1997 
United States 
(Rhode Island) - 
Prospective 
study, Women 
and Infants' 
Hospital (1991-
1993) 
Mothers diagnosed 
with GDM or not 
(control) during 
index pregnancy and 
their LGA and AGA 
infants seen at birth 
then at age 1 year 
192 GDM 
diagnosed 
with criteria: 
1-h 50-gram 
glucose test 
≥130mg/dl, 
then two 
abnormal 
100-gram 
OGTT 
Weight at age 
1 year/ 
weight 
measures 
based on 
gestational 
age and sex, 
anthropometr
-ic measures  
Multiple 
regression 
for 
independent 
effect  
LGA infants of GDM 
mothers compared to all 
other infants: BMI, waist 
girth, abdominal skin folds 
at age 1 higher than all 
other groups (p<0.001) 
Wright et 
al.92 
/2009 
United States 
(Massachusetts) – 
Project Viva, 
prospective 
prebirth cohort 
study (recruited 
1999-2002) Note: 
Only women with 
GDM received 
counselling to 
manage blood 
sugar 
Pregnant women 
(singleton 
pregnancy) and their 
children 
Exclusions: history of 
previous Type I or II 
DM or polycystic 
ovary syndrome 
with IGT 
1238 GDM, IGT, or 
normal 
glucose 
tolerance 
based on 
fasting and 
non-fasting 
OGTT results 
Adiposity at 
age 3/ age- 
and sex- 
specific BMI, 
subscapular 
and triceps  
skinfold 
thickness 
Multivariable 
linear 
regression of 
child BMI and 
skinfolds on 
maternal 
glucose 
tolerance 
during 
pregnancy 
Adiposity assessed by BMI: 
no statistically significant 
impact of maternal 
glucose tolerance 
 
Adiposity assessed by 
skinfolds: Children of GDM 
mothers had skinfolds 
1.31mm thicker than 
other groups (95% CI: 
0.08-2.55; p<0.04) 
Wroblew
ska-
Seniuk et 
al.93 
/2009 
Poland (Poznan) – 
Clinical Hospital 
of Obstetrics and 
Gynecology 
medical records 
Children born at the 
Clinical Hospital of 
Obstetrics and 
Gynecology with 
mothers who had 
PGDM, GDM, or 
normal glucose 
tolerance during 
pregnancy 
185 PGDM, GDM, 
or normal 
glucose 
tolerance 
during 
pregnancy 
from hospital 
records 
Obesity 
and/or 
overweight in 
childhood (3-
9 years)/ age- 
and sex-
specific BMI z-
score 
measured 
continuously 
Differences 
in BMI z-
scores 
between 
groups 
BMI z-scores higher in 
children born to mothers 
with GDM (0.81 ± 1.01) 
than to mothers with 
PGDM (-0.04 ± 1.42) and 
control mothers (0.07 ± 
1.28) 
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AppendixBB: Description of Latent Growth Curve Analysis.  
Latent Growth Curve Modelling: Explanation and Theory 
From a theoretical perspective, latent growth curve modelling (LGCM) is an analytic tool 
used to test hypotheses about unobserved phenomena that are manifest in observed 
measures. As previously mentioned, LGCM is most effective for the analysis of repeated 
measures from multiwave panel data.
160
 The underlying or “latent” phenomenon is 
theorized to have a similar shape to the curves produced by the repeated measures. 
160
 
However, the observed trajectories are limited by the number of recorded observations and 
thus only provide snapshots of the underlying continuous latent trajectories. 
160
 
Unconditional Models 
The first figure below depicts the LGCM used in the current study minus any explanatory 
variables and is therefore the unconditional version of the model (Figure B1). The boxes, y1 
through y5, represent the observed scores at each data collection point.  In the current study, 
these boxes reflect BMI at ages 2, 4, 6, 8, and 10 years. The circles represent the growth 
factors of the latent trajectory and indicate the intercept (α) and the linear slope (β1) and 
quadratic slope (β2) components of the latent trajectory. The intercept and slope growth 
factors are continuous latent variables that serve as the parameters of the latent group-level 
(average) trajectory to be estimated.  In the current study, there was an a priori expectation 
that trajectories would have a quadratic shape since BMI typically declines after the age of 
2 years before beginning a steady incline throughout childhood.
64
 Thus, two latent 
variables describe slope in the current model, whereas a linear model would only have a 
single latent variable for slope.  
In the unconditional model, the observed repeated measures (y1 through y5) are related to 
the continuous latent variables through the following trajectory equation: 
               
                     (1) 
where yit represents the value of the observed measure for the ith individual at time t, λt is a 
constant fixed to values 0, 1, 2, 3, and 4 for the linear component of the slope of the 
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trajectory, and λt
2
 are simply these values squared for the quadratic component of slope. 
The symbol ϵit indicates the random error for each individual observed measure (i) at each 
time point (t).  
The intercept αi is a constant for each individual and thus has a fixed effect on each of the 
measures yit, indicated by fixed factor “loadings” of 1.0 from the latent variable α to each 
of the observed measures y1 to y5 (Figure B1). The individually-varying linear and 
quadratic growth factors β1i and β2i also have fixed factor loadings, λt and λt
2 
respectively, 
since the model imposes a quadratic shape on the data (Figure B1). The three random latent 
variables αi, β1i, and β2i, can be further described by the following three expressions: 
                     (1.1) 
                        (1.2) 
                        (1.3) 
where μα, μβ1, and μβ2 are means of all individual intercept and slope variables and ζαi, ζβ1i, 
and ζβ2i are the individual disturbances or deviations from those means. It is these 
deviations that form the central focus of the analysis and upon which hypotheses are made.   
1.01.0 1.0
1.0
1.0
1.0
2.0
3.0
4.0 1.0
4.0
9.0
16.0
y1 y2 y3 y4 y5 
α β1 β2
0
0
ϵ1 ϵ2 ϵ3 ϵ4 ϵ5
 
Figure B1. Unconditional quadratic latent growth curve model. 
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The majority of the assumptions of the unconditional LGCM also hold true for the 
conditional model. The first is that the mean of the random errors for all individuals and 
time points, or E(ϵit), is equal to zero. Next, it is assumed that all the intercept and slope 
latent variables, αi, β1i, and β2i, are uncorrelated with the random error ϵit for all individuals. 
That is, these variables are assumed not to reflect the disturbance caused by random error. 
It is further assumed that errors within an individual are uncorrelated over time and that 
errors between individuals are also uncorrelated.   
Conditional Models 
In Figure B2 a time-invariant explanatory variable, or covariate, x1 has been added to the 
original model turning the unconditional LGCM into a conditional LGCM. The covariate is 
time-invariant since it is a variable whose effect on the latent trajectory does not vary with 
time. In the current study, the main time-invariant predictor of interest was prenatal 
exposure to GDM, however a more complex conditional model was also used to control for 
the effects of other time-invariant covariates described in Section 2.1.2 (Figure 2.2). In a 
conditional LGCM, added covariates predict the continuous latent trajectory variables and 
thus have a direct impact on the variables αi, β1i, and β2i and an indirect impact on the 
observed variables y1 to y5 (Figure B2). Therefore, the trajectory equation (1) remains the 
same for the conditional model, but the expressions (1.2, 1.3, and 1.4) for the latent 
variables αi, β1i, and β2i change as follows (for a simple conditional LGCM with covariate 
x1): 
                        (1.4) 
                          (1.5) 
                          (1.6) 
where x1i is the value of the covariate for each individual and γα1, γβ1, and γβ2 are the 
coefficients for the covariate in each of the intercept and slope equations. The values of 
these coefficients are the primary outputs of interest from the conditional latent growth 
curve analysis.  
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Figure B2. Conditional quadratic latent growth curve model 
 
Advantages of Latent Growth Curve Modelling 
Latent growth curve modelling has a number of advantages. First, unlike other techniques 
for longitudinal data analysis, it does not make the assumption that there is no 
measurement error.
160
 Indeed, as pictured in Figures B1 and B2, latent growth curve 
analysis incorporates time-specific measurement error into the model (ϵn). Second, it 
provides group-level and individual-level information by producing estimates of the mean 
(group-level) and variance (individual variation) for all parameter estimates. Latent growth 
curve analysis also allows variances of the latent intercept (αi) and slope (β1 and β2) 
variables to be correlated, that is, it allows for covariance. This provides a more realistic 
representation of a longitudinal outcome, since initial levels are likely to correlate with the 
rate of change over time of the outcome.  
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AppendixCC: Additional Model Results.  
Table C1. Model results for the effects of all other covariates in the conditional LGCM by gender. 
 Females (N= 1555) Males (N=1619) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Regression Weights       
        (intercept) ON           
-0.075 (0.025) -3.038 0.002 -0.031 (0.020) -1.527 0.127 
        (intercept) ON          
0.872 (0.238) 3.658 0.000 0.236 (0.208) 1.136 0.256 
        (intercept) ON         0.693 (0.272) 2.554 0.011 0.338 (0.268) 1.262 0.207 
        (intercept) ON          0.211(0.125) 1.692 0.091 -0.005 (0.123) -0.041 0.967 
        (intercept) ON             -0.029 (0.038) -0.775 0.438 -0.019 (0.034) -0.553 0.581 
       
         (linear slope) ON           
0.017 (0.015) 1.120 0.263 0.013 (0.014) 0.933 0.351 
         (linear slope) ON          
-0.133 (0.164) -0.816 0.415 0.005 (0.128) 0.043 0.966 
         (linear slope) ON         -0.170 (0.168) -1.011 0.312 0.079 (0.161) 0.490 0.624 
         (linear slope)  ON          -0.144 (0.105) -1.366 0.172 -0.050 (0.073) -0.680 0.496 
         (linear slope)  ON             -0.022 (0.026) -0.836 0.403 0.004 (0.024) 0.165 0.869 
       
         (quadratic slope) ON           
-0.001 (0.002) -0.545 0.586 -0.002 (0.002) -1.010 0.313 
         (quadratic slope) ON          
0.011 (0.021) 0.554 0.580 0.002 (0.016) 0.104 0.917 
         (quadratic slope) ON         0.028 (0.021) 1.341 0.180 -0.015 (0.021) -0.708 0.479 
         (quadratic slope) ON          0.013 (0.014) 0.886 0.376 -0.002 (0.009) -0.247 0.805 
         (quadratic slope) ON             0.002 (0.003) 0.517 0.605 -0.002 (0.003) -0.582 0.560 
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Table C2. Model results for the effects of all other covariates in the conditional LGCM by breastfeeding for females. 
 Never Breastfed (N= 390) Breastfed (N=1152) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Regression Weights       
        (intercept) ON           
-0.126 (0.048) -2.631 0.009 -0.061 (0.028) -2.185 0.029 
        (intercept) ON          
1.335 (0.463) 2.884 0.004 0.789 (0.275) 2.864 0.004 
        (intercept) ON         1.128 (0.338) 0.768 0.443 0.445 (0.298) 1.495 0.135 
        (intercept) ON          0.075 (0.271) 0.277 0.782 0.189 (0.142) 1.329 0.184 
        (intercept) ON             0.078 (0.095) 0.826 0.409 -0.044 (0.043) -1.020 0.308 
       
         (linear slope) ON           
0.066 (0.028) 2.391 0.017 0.003 (0.018) 0.165 0.869 
         (linear slope) ON          
-0.548 (0.271) -2.020 0.043 -0.016 (0.197) -0.083 0.933 
         (linear slope) ON         -0.247 (0.266) -0.926 0.354 -0.084 (0.197) -0.425 0.671 
         (linear slope)  ON          -0.220 (0.163) -1.346 0.178 -0.114 (0.125) -0.917 0.359 
         (linear slope)  ON             0.014 (0.045) 0.299 0.765 -0.038 (0.032) -1.187 0.235 
       
         (quadratic slope) ON           
-0.006 (0.003) -1.843 0.065 0.000 (0.002) 0.068 0.946 
         (quadratic slope) ON          
0.052 (0.030) 1.731 0.083 -0.002 (0.025) -0.065 0.948 
         (quadratic slope) ON         0.035 (0.030) 1.181 0.238 0.017 (0.025) 0.698 0.485 
         (quadratic slope) ON          0.023 (0.018) 1.336 0.182 0.009 (0.017) 0.532 0.595 
         (quadratic slope) ON             -0.004 (0.005) -0.705 0.481 0.005 (0.004) 1.132 0.258 
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Table C3. Model results for the effects of all other covariates in the conditional LGCM by breastfeeding for males. 
 Never Breastfed (N= 428) Breastfed (N=1169) 
   Est. (S.E.) Est./S.E. p-value Est. (S.E.) Est./S.E. p-value 
Regression Weights       
        (intercept) ON           
0.023 (0.035) 0.664 0.507 -0.056 (0.024) -2.368 0.018 
        (intercept) ON          
-0.245 (0.352) -0.697 0.486 0.451 (0.239) 1.885 0.059 
        (intercept) ON         0.287 (0.389) 0.737 0.461 0.328 (0.349) 0.941 0.347 
        (intercept) ON          -0.420 (0.194) -2.161 0.031 0.099 (0.145) 0.681 0.496 
        (intercept) ON             0.082 (0.067) 1.228 0.220 -0.030 (0.041) -0.719 0.472 
       
         (linear slope) ON           
-0.023 (0.028) -0.827 0.408 0.029 (0.016) 1.838 0.066 
         (linear slope) ON          
0.348 (0.256) 1.356 0.175 -0.139 (0.143) -0.976 0.329 
         (linear slope) ON         -0.201 (0.277) -0.727 0.467 0.163 (0.182) 0.897 0.370 
         (linear slope)  ON          0.196 (0.143) 1.369 0.171 -0.108 (0.081) -1.328 0.184 
         (linear slope)  ON             -0.025 (0.047) -0.526 0.599 0.013 (0.029) 0.441 0.659 
       
         (quadratic slope) ON           
0.004 (0.004) 1.113 0.266 -0.004 (0.002) -1.976 0.048 
         (quadratic slope) ON          
-0.037 (0.034) -1.084 0.278 0.020 (0.017) 1.194 0.232 
         (quadratic slope) ON         0.012 (0.036)  0.333 0.739 -0.017 (0.022) -0.748 0.454 
         (quadratic slope) ON          -0.027 (0.018) -1.515 0.130 0.004 (0.010) 0.427 0.670 
         (quadratic slope) ON             0.000 (0.006) 0.075 0.941 -0.003 (0.003) -0.765 0.444 
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